{"meta":{"query_hash":"f077d746d895","filters":{"venue":"Current Treatment Options in Oncology"},"cohort_total":60,"direct_labels_cover":0,"predictions_cover":60,"exported":60,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/f077d746d895","api":"https://metacan.xera.ac/api/v1/cohort?venue=Current+Treatment+Options+in+Oncology"},"results":[{"id":"W1972311575","doi":"10.1007/s11864-003-0010-2","title":"Therapeutic dilemmas in the management of uterine papillary serous carcinoma","year":2003,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Radiation therapy; Endometrial cancer; Regimen; Oncology; Internal medicine; Gynecologic oncology; Chemotherapy; Stage (stratigraphy); Cancer; Surgery","score_opus":0.19404959641388064,"score_gpt":0.46296769273399485,"score_spread":0.2689180963201142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972311575","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00074857404,0.99164224,0.0000066466596,0.00010259478,0.00072962587,0.0031757432,0.00007835556,0.0000149448615,0.0035013026],"genre_scores_gemma":[0.0014004684,0.99489015,0.00029451723,0.000037482354,0.00009302064,0.0024910304,0.00035657012,0.000032306954,0.00040444746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99743915,0.00053471467,0.00091968826,0.00048654046,0.00023706586,0.00038286173],"domain_scores_gemma":[0.99872214,0.0002868505,0.00026217633,0.0006258487,0.000030156521,0.00007282109],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002412826,0.00048417662,0.0019613595,0.0005300526,0.000041159885,0.000007714616,0.00021934777,0.0002331681,0.00023161813],"category_scores_gemma":[0.000004941887,0.0002722579,0.0005035932,0.0012033604,0.00009809726,0.000026149755,0.000057518933,0.00032578612,0.00004564324],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006780103,0.0047226637,0.00057646265,0.006701021,0.00056728674,0.00045227437,0.00010322791,0.0000014354263,5.668135e-8,0.0014686374,0.00002342746,0.9853157],"study_design_scores_gemma":[0.004851942,0.0021153572,0.0020558313,0.0030457806,0.002406902,0.00018278779,0.00008401146,0.000001172636,2.5943083e-7,0.000115984214,0.984964,0.00017593827],"about_ca_topic_score_codex":0.00005083576,"about_ca_topic_score_gemma":0.000039770843,"teacher_disagreement_score":0.9851398,"about_ca_system_score_codex":0.0021386598,"about_ca_system_score_gemma":0.00030275018,"threshold_uncertainty_score":0.99997294},"labels":[],"label_agreement":null},{"id":"W1976333691","doi":"10.1007/s11864-011-0170-4","title":"How Do I Deal With the Axilla in Patients With a Positive Sentinel Lymph Node?","year":2011,"lang":"en","type":"article","venue":"Current Treatment Options in Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Kingston General Hospital; Cancer Care South East","funders":"","keywords":"Medicine; Axilla; Radiation therapy; Sentinel node; Breast cancer; Surgery; Axillary Lymph Node Dissection; Dissection (medical); Radiology; Sentinel lymph node; Oncology; Internal medicine; Cancer","score_opus":0.019958055427079277,"score_gpt":0.27174749905477225,"score_spread":0.25178944362769295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976333691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962508,0.0010584154,0.00007548643,0.0008304241,0.00008971606,0.0005111718,0.000056175682,0.000010809819,0.0011169722],"genre_scores_gemma":[0.99763817,0.0004365274,0.00092015916,0.000048401893,0.000054353335,0.00059445266,0.00021808456,0.000020959984,0.0000689188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988896,0.00011532751,0.00013746005,0.000431877,0.00010073129,0.00032498254],"domain_scores_gemma":[0.9993792,0.000026266329,0.00009483547,0.00036193855,0.00009065977,0.000047080826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046252655,0.00026464913,0.0002382841,0.000091114656,0.000101850696,0.00001615788,0.00015418418,0.00008684474,0.000008235114],"category_scores_gemma":[0.0000062510835,0.00015126193,0.000050657134,0.00018990586,0.00022680622,0.000008855014,0.00009701628,0.00007405527,0.0000054574057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009625869,0.0028937599,0.97158694,0.0000045605657,0.00023965024,0.000015935313,0.0007822343,0.000027907947,0.000019207433,0.00020773699,0.00006964321,0.023189846],"study_design_scores_gemma":[0.007554865,0.000912723,0.98705846,0.00003604507,0.000103216844,0.000013766946,0.0004562178,0.0000032501193,0.00015671566,0.000021450403,0.0034936925,0.0001896215],"about_ca_topic_score_codex":0.00008767533,"about_ca_topic_score_gemma":0.00045874092,"teacher_disagreement_score":0.023000225,"about_ca_system_score_codex":0.00040545224,"about_ca_system_score_gemma":0.0001474604,"threshold_uncertainty_score":0.61682826},"labels":[],"label_agreement":null},{"id":"W1981857209","doi":"10.1007/s11864-007-0037-x","title":"Novel Therapies Targeting the Apoptosis Pathway for the Treatment of Acute Myeloid Leukemia","year":2007,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research","keywords":"XIAP; Medicine; Myeloid leukemia; Apoptosis; Cancer research; Leukemia; Inhibitor of apoptosis; Caspase; Programmed cell death; Immunology; Bioinformatics; Biology","score_opus":0.08527216299490954,"score_gpt":0.38885552095560605,"score_spread":0.3035833579606965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981857209","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020638695,0.9887889,0.0066675595,0.000061423496,0.0012295829,0.0026528463,0.00032021187,0.00000956336,0.00006350045],"genre_scores_gemma":[0.00012733926,0.9931823,0.0017187498,0.0000073793376,0.0005561931,0.0022341863,0.0016744107,0.000043189895,0.00045622067],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99832106,0.00012734585,0.00064976735,0.0004648445,0.00009829817,0.00033870654],"domain_scores_gemma":[0.9986006,0.0003307033,0.00042845632,0.00052346557,0.0000772268,0.000039534945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027908487,0.0004513676,0.00082976377,0.00012226168,0.00024144189,0.000016913948,0.0002582644,0.00041515345,0.00001218188],"category_scores_gemma":[0.000012334735,0.00021637928,0.0008080195,0.00018483798,0.00016044121,0.0000029941011,0.000045902867,0.000098220924,0.0000033474867],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039186216,0.0008591376,0.0000020335524,0.00018213401,0.00092267734,4.3441426e-7,0.00018931513,0.00006958227,0.00073052617,0.0005595454,0.00008538837,0.99636006],"study_design_scores_gemma":[0.0010738579,0.001980145,0.0000054479233,0.00020630364,0.0013737446,0.000011580754,0.000100176905,0.000054586573,0.000707596,0.00002765948,0.99426,0.00019886777],"about_ca_topic_score_codex":0.000027423497,"about_ca_topic_score_gemma":0.00006615146,"teacher_disagreement_score":0.99616116,"about_ca_system_score_codex":0.00083541265,"about_ca_system_score_gemma":0.0005298149,"threshold_uncertainty_score":0.8823691},"labels":[],"label_agreement":null},{"id":"W1984083792","doi":"10.1007/s11864-012-0181-9","title":"Patients With Metastatic Breast Cancer Using Bevacizumab as a Treatment: Is There Still a Role for it?","year":2012,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Bevacizumab; Medicine; Metastatic breast cancer; Oncology; Breast cancer; Clinical trial; Angiogenesis; Internal medicine; Cancer; Vascular endothelial growth factor; Biomarker; Chemotherapy; Colorectal cancer; Paclitaxel; Metastasis; VEGF receptors","score_opus":0.19670101289944478,"score_gpt":0.50025470231862,"score_spread":0.30355368941917527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984083792","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004587392,0.98080677,0.000010242895,0.00024386277,0.0010560133,0.0084339185,0.004527694,0.00005624425,0.00027788547],"genre_scores_gemma":[0.0008587619,0.982291,0.00070354267,0.00005978234,0.0004910349,0.011937161,0.0025716245,0.00014746453,0.0009396707],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99685353,0.00027900448,0.00085232523,0.00090086146,0.0002182663,0.0008960351],"domain_scores_gemma":[0.997975,0.00038094536,0.0005965356,0.0005162945,0.0001911356,0.00034006924],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008659296,0.0011019101,0.0031741536,0.00062697666,0.00016300223,0.000023654005,0.00014659739,0.0003490504,0.0015606369],"category_scores_gemma":[0.0000062081895,0.00069518306,0.0007917248,0.00052125374,0.00016399809,0.0001335735,0.000045228175,0.00027170888,0.00010601232],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000891552,0.018293114,0.002624936,0.0021875412,0.0038437962,0.000034879155,0.0008692608,0.000008087879,2.1512665e-7,0.000045834448,0.00015467759,0.9710461],"study_design_scores_gemma":[0.018270962,0.00695263,0.00027479816,0.0034435797,0.03482242,0.00026091674,0.00007985187,0.000038735343,0.0000010155042,0.000021043568,0.9353353,0.0004987703],"about_ca_topic_score_codex":0.00055997085,"about_ca_topic_score_gemma":0.0005863611,"teacher_disagreement_score":0.9705473,"about_ca_system_score_codex":0.0119738905,"about_ca_system_score_gemma":0.002975421,"threshold_uncertainty_score":0.9995499},"labels":[],"label_agreement":null},{"id":"W1986529943","doi":"10.1007/s11864-000-0051-8","title":"Anaplastic thyroid carcinoma","year":2000,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Radiation therapy; Malignancy; Surgery; Thyroidectomy; Chemotherapy; Thyroid; Cause of death; Disease; Thyroid carcinoma; Carcinoma; Anaplastic carcinoma; Internal medicine","score_opus":0.1219183256818262,"score_gpt":0.43924084772073996,"score_spread":0.31732252203891376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986529943","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027862395,0.99155027,0.000002137778,0.00012127938,0.0011858223,0.0026073237,0.000245667,0.00008615876,0.0039227023],"genre_scores_gemma":[0.0002563998,0.9920677,0.00019198601,0.000018029186,0.00048068786,0.0046999096,0.0015381619,0.00007913089,0.0006680171],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971295,0.0002469593,0.0009321625,0.0009005093,0.00019104731,0.00059983146],"domain_scores_gemma":[0.9983004,0.00040297455,0.00024739758,0.00073858537,0.00003710312,0.0002735366],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007717343,0.0007917607,0.003012474,0.00077948585,0.00009713062,0.000020854144,0.00015496787,0.0004502086,0.00077776145],"category_scores_gemma":[0.000018941933,0.0005679388,0.0009065441,0.0006014957,0.0001300849,0.0000461478,0.00004609169,0.0004624391,0.0009968554],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060940885,0.0056291013,0.000278755,0.0015625384,0.0003766553,0.00044335658,0.000060252703,0.000004917614,1.9328958e-8,0.00027713605,0.0015890037,0.9897173],"study_design_scores_gemma":[0.0036629906,0.004844083,0.00031475397,0.00513842,0.0044793095,0.00042899424,0.000012648908,0.0000058305736,2.266352e-7,0.000023030147,0.9807409,0.00034880912],"about_ca_topic_score_codex":0.000048469843,"about_ca_topic_score_gemma":0.00015015858,"teacher_disagreement_score":0.9893685,"about_ca_system_score_codex":0.0072808163,"about_ca_system_score_gemma":0.0019310713,"threshold_uncertainty_score":0.999781},"labels":[],"label_agreement":null},{"id":"W1989321952","doi":"10.1007/s11864-001-0035-3","title":"Hairy cell leukemia","year":2001,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Deoxycoformycin; Neutropenia; Regimen; Hairy cell leukemia; Hairy Cell; Pentostatin; Febrile neutropenia; Internal medicine; Leukopenia; Gastroenterology; Cladribine; Leukemia; Surgery; Chemotherapy; Rituximab; Lymphoma","score_opus":0.1982134664980968,"score_gpt":0.49475473741481496,"score_spread":0.29654127091671817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989321952","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006300954,0.9757792,0.000019405714,0.000043946624,0.0012724428,0.002874457,0.00005568007,0.000106199805,0.019785695],"genre_scores_gemma":[0.000011317284,0.9887089,0.00052720634,0.000013280254,0.0006727783,0.0021257084,0.0011272241,0.00009766449,0.006715916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963596,0.00040125585,0.0010724104,0.0009388772,0.00034595662,0.0008819428],"domain_scores_gemma":[0.9975857,0.0006604931,0.00027560614,0.0010529443,0.00008159491,0.00034366245],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002683302,0.00071577355,0.0029448986,0.0010150757,0.00009347891,0.000022402257,0.00029839433,0.0008171675,0.0006866672],"category_scores_gemma":[0.000080677346,0.000536156,0.00084380584,0.001095492,0.0002464405,0.000053990276,0.0001705891,0.0009341833,0.002112427],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00003439617,0.0022330969,0.000009494394,0.005924574,0.00016959547,0.0011041644,0.00006075173,0.000009746304,9.409767e-8,0.00014321061,0.0029656838,0.9873452],"study_design_scores_gemma":[0.011710457,0.001449499,0.000002805338,0.006102599,0.0015824699,0.001483504,0.00002602363,0.00019861272,4.8815383e-7,0.000023073864,0.977085,0.00033549825],"about_ca_topic_score_codex":0.00019028476,"about_ca_topic_score_gemma":0.00012339577,"teacher_disagreement_score":0.9870097,"about_ca_system_score_codex":0.24378678,"about_ca_system_score_gemma":0.052487932,"threshold_uncertainty_score":0.999709},"labels":[],"label_agreement":null},{"id":"W1992830240","doi":"10.1007/s11864-000-0044-7","title":"Fibrous tumors of the pleura","year":2000,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Parietal Pleura; Solitary fibrous tumor; Resection; Radiation therapy; Atypia; Mesenchymal Tumor; Chemotherapy; Pathology; Surgical resection; Radiology; Surgery; Lung; Immunohistochemistry; Internal medicine","score_opus":0.16379476148943808,"score_gpt":0.4657108679892071,"score_spread":0.30191610649976897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992830240","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004685992,0.99276346,4.0504284e-7,0.00011506649,0.0009135776,0.0022065414,0.00012934495,0.00004386107,0.003359132],"genre_scores_gemma":[0.00010104767,0.9972586,0.00012905746,0.00000741998,0.00021347494,0.00095670146,0.0001442153,0.000041450417,0.0011480461],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979149,0.00028828473,0.0008767518,0.00042216663,0.0001761479,0.00032175094],"domain_scores_gemma":[0.9983995,0.00043987384,0.0003456459,0.00070188043,0.000043651165,0.00006942685],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000093972696,0.0004512168,0.002469082,0.00034493234,0.00007890621,0.000003760857,0.0001841704,0.00019358186,0.00025449623],"category_scores_gemma":[0.0000965211,0.00026005477,0.00073917356,0.00066937547,0.00032851988,0.000018678737,0.00009519951,0.00039804037,0.00015243012],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018245915,0.0013985329,0.00020069147,0.0027192107,0.00022543519,0.0001145138,0.00016221113,0.0000020956215,5.356422e-8,0.00019850234,0.0006883369,0.9942722],"study_design_scores_gemma":[0.001069351,0.0008619026,0.00029424243,0.010125764,0.0021635669,0.0007602762,0.000040033112,0.0000012571336,4.8043546e-7,0.00002517493,0.98449916,0.00015878923],"about_ca_topic_score_codex":0.000026496708,"about_ca_topic_score_gemma":0.00003650632,"teacher_disagreement_score":0.9941134,"about_ca_system_score_codex":0.0019347226,"about_ca_system_score_gemma":0.0010805691,"threshold_uncertainty_score":0.99998516},"labels":[],"label_agreement":null},{"id":"W1993779176","doi":"10.1007/s11864-010-0131-3","title":"Acupuncture in the Oncology Setting: Clinical Trial Update","year":2010,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Acupuncture Treatment Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Acupuncture; Medicine; Alternative medicine; Clinical trial; Nausea; Clinical Oncology; Intensive care medicine; Vomiting; Oncology; Health care; Cancer; Integrative medicine; Internal medicine; Physical therapy; Pathology","score_opus":0.36484198333567686,"score_gpt":0.6154089993036927,"score_spread":0.2505670159680159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993779176","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035450087,0.9745526,0.00000473467,0.0047357082,0.0040051937,0.013047942,0.00011654263,0.00007713014,0.0031056744],"genre_scores_gemma":[0.000039327668,0.985428,0.000992613,0.00017564274,0.0021866236,0.008842633,0.0018687116,0.00006931325,0.00039713288],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9911351,0.0035673461,0.00238339,0.0013287473,0.0005105304,0.0010748626],"domain_scores_gemma":[0.99100864,0.006484693,0.00073735433,0.00139161,0.00012331492,0.00025435854],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0024839758,0.0015167181,0.006856951,0.00097577117,0.00020381482,0.000039285773,0.0006477685,0.001944387,0.00023971492],"category_scores_gemma":[0.0013879915,0.0005538016,0.002060439,0.0009983752,0.00077671115,0.00007036446,0.0002832249,0.0043997033,0.00045467768],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002144543,0.012043784,0.00029747846,0.00086297566,0.00062243454,0.0010389682,0.00028757245,3.9415752e-7,3.5158244e-8,0.0003915885,0.006475784,0.9758344],"study_design_scores_gemma":[0.03959916,0.00806186,0.00019703749,0.0015953138,0.004164053,0.00050898455,0.00011359859,0.0000028580353,4.1455188e-8,0.00010456572,0.9453256,0.00032693983],"about_ca_topic_score_codex":0.000022123933,"about_ca_topic_score_gemma":0.00088553026,"teacher_disagreement_score":0.9755075,"about_ca_system_score_codex":0.004917369,"about_ca_system_score_gemma":0.0045915274,"threshold_uncertainty_score":0.9997582},"labels":[],"label_agreement":null},{"id":"W1995399432","doi":"10.1007/s11864-006-0003-z","title":"Active surveillance versus radical treatment for favorable-risk localized prostate cancer","year":2006,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Watchful waiting; Prostate cancer; Prostatectomy; Prostate-specific antigen; Cancer; Incidence (geometry); Prostate; Internal medicine; Oncology; Gynecology; Surgery","score_opus":0.13702066434122007,"score_gpt":0.46769272392195926,"score_spread":0.3306720595807392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995399432","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003699046,0.97670084,0.00003283571,0.0003001658,0.0029153435,0.012121867,0.007065023,0.00012159075,0.00037243366],"genre_scores_gemma":[0.00006245224,0.9403271,0.0007194801,0.000009240682,0.00060812663,0.04974452,0.0076994947,0.0001328947,0.0006967126],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955036,0.0005026369,0.0012764692,0.0014578773,0.00024891278,0.0010105036],"domain_scores_gemma":[0.9965091,0.0014476408,0.0007988227,0.0007475647,0.00016157288,0.00033530162],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018976248,0.0012431218,0.0043595107,0.0005506213,0.00025335612,0.00003705827,0.00016065528,0.00058531476,0.000114607865],"category_scores_gemma":[0.00006994301,0.0008607303,0.0013629437,0.0006119284,0.00029655997,0.00007543134,0.00005064324,0.00040893376,0.000065568725],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017351166,0.008919808,0.0009590309,0.0019671053,0.002188087,0.00010798425,0.00014404085,0.00007007404,5.8571302e-8,0.00013793568,0.0011911667,0.9825796],"study_design_scores_gemma":[0.028974965,0.01041534,0.00018730712,0.0037318377,0.006375059,0.000030050373,0.000034681692,0.00005368498,0.000003948115,0.000039112423,0.94958663,0.00056739897],"about_ca_topic_score_codex":0.0010022223,"about_ca_topic_score_gemma":0.0023379854,"teacher_disagreement_score":0.9820122,"about_ca_system_score_codex":0.02619952,"about_ca_system_score_gemma":0.004432819,"threshold_uncertainty_score":0.99938434},"labels":[],"label_agreement":null},{"id":"W2005915945","doi":"10.1007/s11864-003-0046-3","title":"Techniques to modulate radiotherapy toxicity and outcome in soft tissue sarcoma","year":2003,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Radiation therapy; Medicine; Soft tissue sarcoma; Radiation treatment planning; Soft tissue; Sarcoma; Outcome (game theory); Medical physics; Radiology; Pathology","score_opus":0.1376600363875104,"score_gpt":0.47756572821689297,"score_spread":0.3399056918293826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005915945","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015712717,0.992485,0.00008788344,0.0004688574,0.0003772432,0.0046250043,0.00005938659,0.000076229255,0.00024915085],"genre_scores_gemma":[0.00018241788,0.9885551,0.007491593,0.00010940094,0.000097753415,0.0031417368,0.00017965901,0.000063447376,0.00017892578],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973086,0.00032625845,0.0009169534,0.00081867666,0.0001423941,0.00048708575],"domain_scores_gemma":[0.99870455,0.00029303142,0.00018295128,0.00055510533,0.00003106965,0.00023331262],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023091858,0.0006522403,0.002848075,0.00084972417,0.00006514503,0.000021270433,0.00011383187,0.00044795245,0.00014321209],"category_scores_gemma":[0.000034221026,0.00050089636,0.0002943183,0.00048485977,0.00009252915,0.000040531137,0.0000530388,0.0003518835,0.00007326565],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019825458,0.006921232,0.007934271,0.00078944274,0.00015676368,0.00031029634,0.00013911583,0.0000015811409,7.8526006e-7,0.0001471987,0.00019934196,0.98338014],"study_design_scores_gemma":[0.0023966955,0.0019488872,0.0015551671,0.0032186755,0.00062214286,0.00034332287,0.000012421433,0.0000066777216,0.0000033538004,0.000055400586,0.98950136,0.00033590707],"about_ca_topic_score_codex":0.00009467152,"about_ca_topic_score_gemma":0.00027793826,"teacher_disagreement_score":0.989302,"about_ca_system_score_codex":0.004093247,"about_ca_system_score_gemma":0.0003282139,"threshold_uncertainty_score":0.9997443},"labels":[],"label_agreement":null},{"id":"W2006223990","doi":"10.1007/s11864-001-0029-1","title":"Adrenal cortical carcinoma","year":2001,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Mitotane; Adrenocortical carcinoma; Chemotherapy; Surgical resection; Endocrine system; Carcinoma; Primary tumor; Disease; Pathogenesis; Oncology; Surgery; Internal medicine; Pathology; Cancer; Hormone; Metastasis","score_opus":0.19454005017584966,"score_gpt":0.4721638713513562,"score_spread":0.27762382117550655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006223990","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045288278,0.9929245,0.000025227379,0.00008803139,0.0011187232,0.0013795537,0.00006658773,0.0000631178,0.0038813394],"genre_scores_gemma":[0.0002164427,0.9953444,0.00022016732,0.00001535741,0.000664523,0.00081818027,0.0010845714,0.000042983593,0.00159336],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975778,0.0003061214,0.0008505826,0.00058621925,0.00016748712,0.000511816],"domain_scores_gemma":[0.9986904,0.0003430577,0.00020335868,0.0004420547,0.000046984187,0.00027414766],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001225908,0.00052741455,0.002309698,0.00054048817,0.00008661559,0.000009425148,0.0001292765,0.0004177209,0.0008098798],"category_scores_gemma":[0.000055125423,0.00036258338,0.0006860491,0.00065761094,0.0001768796,0.00002939874,0.000059066166,0.00076507765,0.0008287987],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004131109,0.0026518917,0.00020223139,0.0011691019,0.00013101389,0.006989116,0.000041670934,0.0000011115278,8.4873975e-9,0.00083808356,0.00062093016,0.9873135],"study_design_scores_gemma":[0.0018149088,0.0015149082,0.00047236434,0.0035051368,0.002177568,0.01739047,0.000016768543,0.000015471089,8.474439e-8,0.000030136503,0.9728035,0.00025869958],"about_ca_topic_score_codex":0.000018858414,"about_ca_topic_score_gemma":0.000038338283,"teacher_disagreement_score":0.9870548,"about_ca_system_score_codex":0.0024982686,"about_ca_system_score_gemma":0.0016138337,"threshold_uncertainty_score":0.99994916},"labels":[],"label_agreement":null},{"id":"W2013328103","doi":"10.1007/s11864-008-0064-2","title":"Mind–Body Interventions in Oncology","year":2008,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"Alberta Cancer Foundation","keywords":"Medicine; Psychological intervention; Clinical Oncology; Oncology; Internal medicine; Medical physics; Cancer; Nursing","score_opus":0.4492024423256736,"score_gpt":0.5819832848128068,"score_spread":0.13278084248713323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013328103","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00063517,0.9889684,0.000026585016,0.00032664737,0.0023592743,0.0026715924,0.00013117856,0.00003082581,0.004850331],"genre_scores_gemma":[0.00014109815,0.9940019,0.0004885266,0.000014476325,0.00059632625,0.002419397,0.0013992945,0.00003513562,0.0009038212],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963615,0.000605574,0.0015908495,0.0007338492,0.000171626,0.0005366338],"domain_scores_gemma":[0.9981094,0.00083956926,0.00041420944,0.00042329045,0.00006562732,0.0001479163],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020210458,0.00061841647,0.003404812,0.0015450554,0.00011170472,0.0000047746566,0.0001950083,0.0001506925,0.0007665921],"category_scores_gemma":[0.0001421982,0.00046645582,0.0010105957,0.0007251857,0.00033844818,0.000051095532,0.00017888352,0.0007997934,0.00025266438],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003430805,0.008171238,0.0013895174,0.0018697245,0.00048412252,0.00088993186,0.00040355953,0.0000011887496,7.659267e-8,0.00029086389,0.0008705188,0.9855949],"study_design_scores_gemma":[0.004373475,0.005474038,0.00074967614,0.014436081,0.0012889629,0.000742964,0.00025556266,0.0000066103607,1.40822e-7,0.00003265482,0.97237575,0.00026411182],"about_ca_topic_score_codex":0.00007398443,"about_ca_topic_score_gemma":0.0010729674,"teacher_disagreement_score":0.9853308,"about_ca_system_score_codex":0.0063289404,"about_ca_system_score_gemma":0.0011277654,"threshold_uncertainty_score":0.9997787},"labels":[],"label_agreement":null},{"id":"W2021641747","doi":"10.1007/s11864-004-0034-2","title":"Primary multidisciplinary management of extremity soft tissue sarcomas","year":2004,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Neurovascular bundle; Soft tissue; Sarcoma; Synovial sarcoma; Radiology; Magnetic resonance imaging; Soft tissue sarcoma; Radiation therapy; Biopsy; Surgery; Pathology","score_opus":0.1259279128298919,"score_gpt":0.45353530314396673,"score_spread":0.3276073903140748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021641747","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002133722,0.9915159,0.0000368934,0.00010082778,0.0008093236,0.004462295,0.00017619914,0.00007310999,0.0026121305],"genre_scores_gemma":[0.00015880457,0.9883828,0.005649523,0.000004443987,0.000114671704,0.0034063417,0.0018294214,0.00007296944,0.00038098864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967062,0.00023627697,0.0013283981,0.0009081007,0.0002946819,0.0005263267],"domain_scores_gemma":[0.9979341,0.00033822877,0.0005140735,0.00094826473,0.00006158551,0.00020372622],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017684187,0.00079594296,0.0033038708,0.00069586333,0.000092348935,0.000009177621,0.00021921881,0.00044247808,0.00016529474],"category_scores_gemma":[0.000009520576,0.0005924076,0.0008515295,0.00060044316,0.00021432461,0.000053385746,0.00024598368,0.00037424132,0.00019893971],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043209675,0.022363255,0.0011133539,0.017629398,0.00095869356,0.0012265573,0.000088210385,0.000008441364,1.7795622e-7,0.00094394345,0.00007625575,0.9555485],"study_design_scores_gemma":[0.005093853,0.001366899,0.003622397,0.030948855,0.006397844,0.00035976607,0.000047029116,0.0000022513223,0.0000017748661,0.00014106667,0.951642,0.00037626352],"about_ca_topic_score_codex":0.000034286604,"about_ca_topic_score_gemma":0.000021666405,"teacher_disagreement_score":0.95517224,"about_ca_system_score_codex":0.007966752,"about_ca_system_score_gemma":0.0010540866,"threshold_uncertainty_score":0.99965274},"labels":[],"label_agreement":null},{"id":"W2037730446","doi":"10.1007/s11864-000-0070-5","title":"Localized bladder cancer","year":2000,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Royal College of Physicians and Surgeons of Canada","keywords":"Medicine; Bladder cancer; Cancer; Urology; Oncology; Internal medicine","score_opus":0.16678015950950023,"score_gpt":0.49227819900583614,"score_spread":0.32549803949633593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037730446","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015833308,0.9870973,0.0000063342513,0.00014916771,0.0015017178,0.002939972,0.00038360892,0.00010317138,0.007802885],"genre_scores_gemma":[0.0000060408165,0.988282,0.00021577149,0.000052263487,0.00061706174,0.0063138516,0.0010200233,0.00009377006,0.0033991714],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99723965,0.00027770165,0.00087538233,0.00082547497,0.00020118931,0.0005806094],"domain_scores_gemma":[0.9987314,0.00015360511,0.0002086969,0.00061546336,0.000045986235,0.00024485597],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000725922,0.000765621,0.0029869503,0.00059092796,0.00008971183,0.000017531325,0.0001536437,0.00055790297,0.0043086563],"category_scores_gemma":[0.000010346691,0.0005395225,0.0008345346,0.0006010844,0.00015796718,0.000049460414,0.000037429618,0.00049320963,0.00082876586],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008719363,0.003572135,0.00007496894,0.0014386028,0.0009035114,0.00015942263,0.00008253217,0.0000038682106,2.4511724e-8,0.00007441857,0.0016226899,0.9919806],"study_design_scores_gemma":[0.0046910956,0.0012434808,0.000023464265,0.005922433,0.006137218,0.00018935298,0.000010003354,0.0000058907863,2.9734227e-7,0.00003614252,0.98139066,0.0003499679],"about_ca_topic_score_codex":0.00020777903,"about_ca_topic_score_gemma":0.00020815525,"teacher_disagreement_score":0.9916307,"about_ca_system_score_codex":0.0052769314,"about_ca_system_score_gemma":0.003309289,"threshold_uncertainty_score":0.9999492},"labels":[],"label_agreement":null},{"id":"W2047220014","doi":"10.1007/s11864-010-0137-x","title":"How Affordable are Targeted Therapies in Non-Small Cell Lung Cancer?","year":2011,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pemetrexed; Lung cancer; Oncology; Epidermal growth factor receptor; Chemotherapy; Vascular endothelial growth factor; Targeted therapy; Internal medicine; Quality of life (healthcare); Cancer; VEGF receptors; Cisplatin","score_opus":0.08467429622991147,"score_gpt":0.42896544193682934,"score_spread":0.3442911457069179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047220014","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00051565864,0.9909813,0.000030370145,0.00024217121,0.0014712439,0.0043396093,0.00031154623,0.00005941241,0.0020487083],"genre_scores_gemma":[0.00034169506,0.9837768,0.0008700821,0.000016260345,0.0002260308,0.009868492,0.0010327247,0.0000807485,0.003787162],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977398,0.00018695644,0.00064124214,0.00072989,0.0001086151,0.000593482],"domain_scores_gemma":[0.99862957,0.00013310055,0.00046250067,0.0005291364,0.00008334908,0.00016235556],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009212164,0.00069355045,0.002286935,0.0008541376,0.00010279299,0.000032293854,0.00017360048,0.0004435791,0.00019637772],"category_scores_gemma":[0.000012256762,0.00049636926,0.00048165384,0.0006769872,0.00009076946,0.000091937414,0.000051671832,0.0004651147,0.00003627382],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028176411,0.0046060844,0.004333225,0.0048646308,0.00065755716,0.00013515883,0.0012041739,0.000008481472,3.731573e-7,0.00013027205,0.0005944818,0.98343736],"study_design_scores_gemma":[0.0040083183,0.0007196867,0.00079271675,0.008321277,0.0039059464,0.000027978962,0.00036405562,0.00002232216,0.0000015595077,0.000023547678,0.9814497,0.00036288975],"about_ca_topic_score_codex":0.00042597536,"about_ca_topic_score_gemma":0.001806844,"teacher_disagreement_score":0.9830745,"about_ca_system_score_codex":0.0068048663,"about_ca_system_score_gemma":0.0021050018,"threshold_uncertainty_score":0.99974877},"labels":[],"label_agreement":null},{"id":"W2051653983","doi":"10.1007/s11864-002-0045-9","title":"Elderly patients with lung cancer: Biases and evidence","year":2002,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Medicine; Lung cancer; Internal medicine; Radiation therapy; Neutropenia; Chemotherapy; Clinical trial; Performance status; Oncology; Cancer; Surgery","score_opus":0.26352508198025576,"score_gpt":0.5318729844685911,"score_spread":0.26834790248833534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051653983","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000768429,0.9947879,0.0000019338431,0.00023603976,0.00038423546,0.0034998446,0.00011621573,0.000041510757,0.0001639055],"genre_scores_gemma":[0.00010768673,0.9944043,0.0001507544,0.000007323314,0.00016437302,0.004625592,0.00013288045,0.00003736322,0.00036971914],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979572,0.00022342739,0.00046100625,0.000645393,0.00027370497,0.00043921702],"domain_scores_gemma":[0.99826604,0.00083925395,0.00021327773,0.0003749773,0.00013833262,0.0001681432],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000090580004,0.0004636941,0.0018150833,0.00047761004,0.000116769996,0.00001945859,0.00010605568,0.00017120472,0.00013300762],"category_scores_gemma":[0.0001839229,0.00028498558,0.00015868442,0.00048743552,0.00027070325,0.000092374954,0.000095372736,0.00039447477,0.000019947955],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047185153,0.0013535554,0.01613366,0.0076824534,0.0005142258,0.000047269918,0.00011769991,0.0000014229312,4.948198e-9,0.0000148689705,0.001190309,0.97289735],"study_design_scores_gemma":[0.0023406935,0.003669889,0.0018706009,0.061821904,0.0028804329,0.000026209264,0.0000119156175,0.000013077586,2.9838283e-8,0.0000013250296,0.9271356,0.00022834168],"about_ca_topic_score_codex":0.000113722715,"about_ca_topic_score_gemma":0.00030335062,"teacher_disagreement_score":0.972669,"about_ca_system_score_codex":0.0050693606,"about_ca_system_score_gemma":0.0010445311,"threshold_uncertainty_score":0.99996024},"labels":[],"label_agreement":null},{"id":"W2051710823","doi":"10.1007/s11864-012-0221-5","title":"Active Surveillance for Prostate Cancer: Overview and Update","year":2013,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Overdiagnosis; Medicine; Prostate cancer; Disease; Watchful waiting; Intensive care medicine; Cancer; Adverse effect; Quality of life (healthcare); Gynecology; Internal medicine; Oncology","score_opus":0.1570997929151768,"score_gpt":0.4764837217120425,"score_spread":0.3193839287968657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051710823","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001837349,0.9864875,0.0000035676846,0.00066497596,0.0009350032,0.009565842,0.0020112938,0.000045255045,0.000102840284],"genre_scores_gemma":[0.000016213904,0.9544119,0.00042367438,0.00003353589,0.00020652548,0.042497784,0.00209038,0.00006290246,0.0002570476],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99771327,0.00017315672,0.00068605377,0.0008228687,0.000103259554,0.00050137925],"domain_scores_gemma":[0.99849266,0.0004031496,0.0003926393,0.00039133994,0.0001191989,0.00020099737],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011459903,0.0006337698,0.0026542614,0.0002943299,0.00009703982,0.000027446222,0.00008361667,0.00026710148,0.000114880044],"category_scores_gemma":[0.000026334717,0.00043752577,0.00040552154,0.00028313545,0.00013079178,0.00007772043,0.00006462428,0.00023693108,0.00005268995],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005639467,0.0015514247,0.0005433175,0.007075146,0.0006198128,0.00001945245,0.000085392385,0.0000010883423,5.1052407e-8,0.0003712365,0.0011255569,0.98855114],"study_design_scores_gemma":[0.0036683914,0.0017519675,0.0003785863,0.007835931,0.0017693131,0.00004966106,0.00001717407,0.0000113640235,0.0000010305824,0.00009902859,0.9841076,0.00030992847],"about_ca_topic_score_codex":0.00011122475,"about_ca_topic_score_gemma":0.00027540652,"teacher_disagreement_score":0.9882412,"about_ca_system_score_codex":0.004352353,"about_ca_system_score_gemma":0.0013135914,"threshold_uncertainty_score":0.99980766},"labels":[],"label_agreement":null},{"id":"W2055188674","doi":"10.1007/s11864-002-0034-z","title":"Follicular thyroid carcinoma","year":2002,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Thyroidectomy; Thyroid carcinoma; Thyroid; Surgery; Follicular carcinoma; Total thyroidectomy; Carcinoma; Follicular phase; Nodule (geology); Internal medicine; Papillary carcinoma","score_opus":0.15706304479701474,"score_gpt":0.43728520014422634,"score_spread":0.2802221553472116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055188674","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014763621,0.9917596,0.0000040522173,0.0002136213,0.0013168328,0.0031741867,0.0001616651,0.000090724854,0.0031317088],"genre_scores_gemma":[0.00015617555,0.9907906,0.00032119994,0.000021045902,0.0004980561,0.006179151,0.0010333769,0.00008725851,0.00091310474],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969925,0.00027054988,0.0009561993,0.0009425381,0.00022284125,0.00061534304],"domain_scores_gemma":[0.9981957,0.00026433417,0.00031941835,0.000889459,0.000055637156,0.0002754246],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009652432,0.00082811376,0.003218749,0.00071456947,0.00010201912,0.000021963773,0.00016824454,0.0005138123,0.0005044837],"category_scores_gemma":[0.000023534298,0.00059070496,0.0012571112,0.0006163476,0.00011506149,0.000048153797,0.000071657334,0.0004680515,0.00091330317],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013303656,0.006820855,0.00041070176,0.0016888868,0.00051404274,0.00059612765,0.00007524825,0.0000018002397,5.1970247e-8,0.00052143773,0.0027203837,0.9866372],"study_design_scores_gemma":[0.0038183203,0.0029375006,0.00019707385,0.004495125,0.004965731,0.0004485239,0.000015731312,0.000007981988,4.870548e-7,0.000019278274,0.98272234,0.00037190193],"about_ca_topic_score_codex":0.000049017373,"about_ca_topic_score_gemma":0.0000613865,"teacher_disagreement_score":0.98626524,"about_ca_system_score_codex":0.008275662,"about_ca_system_score_gemma":0.00090211886,"threshold_uncertainty_score":0.9998646},"labels":[],"label_agreement":null},{"id":"W2058686345","doi":"10.1007/s11864-004-0044-0","title":"Adenocarcinoma of the cervix","year":2004,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Adenocarcinoma; Stage (stratigraphy); Cervix; Radiation therapy; Hysterectomy; Radical Hysterectomy; Cervical cancer; Incidence (geometry); Disease; Surgery; Radical surgery; Oncology; Internal medicine; Cancer","score_opus":0.18088694354339682,"score_gpt":0.46256375068650873,"score_spread":0.28167680714311194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058686345","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010345192,0.994166,0.0000021977312,0.0001330245,0.0015433943,0.0021988228,0.00013190751,0.000022351802,0.0016988259],"genre_scores_gemma":[0.000406604,0.9976235,0.00014976927,0.000010419235,0.0002113215,0.0009542738,0.00021179342,0.000032619915,0.00039968756],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980109,0.00023143525,0.00081318984,0.0004325093,0.00020674436,0.00030527482],"domain_scores_gemma":[0.99857795,0.0002645099,0.0003600227,0.0006329418,0.00005326155,0.000111282774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008590815,0.00041827813,0.0021507384,0.00039990508,0.000056090532,0.000004695495,0.00022000342,0.00033705283,0.0002658727],"category_scores_gemma":[0.000052907893,0.00022050278,0.0010302229,0.0011149402,0.00016906112,0.000022571094,0.00010118854,0.00035793966,0.000095683165],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035651257,0.0032088307,0.00053035753,0.0047235396,0.00033466835,0.000024730398,0.00006134802,0.0000022337017,6.542306e-8,0.000701061,0.000031971744,0.99034554],"study_design_scores_gemma":[0.004363758,0.0015274212,0.0011476572,0.0109611945,0.0036362505,0.0001268043,0.000015730415,3.7614288e-7,0.000001600449,0.00015966168,0.97791153,0.0001479982],"about_ca_topic_score_codex":0.00010567801,"about_ca_topic_score_gemma":0.00006568329,"teacher_disagreement_score":0.99019754,"about_ca_system_score_codex":0.004996654,"about_ca_system_score_gemma":0.0020242196,"threshold_uncertainty_score":0.998823},"labels":[],"label_agreement":null},{"id":"W2066277295","doi":"10.1007/s11864-004-0036-0","title":"Rehabilitation and quality-of-life issues in patients with extremity soft tissue sarcoma","year":2004,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Rehabilitation; Psychosocial; Quality of life (healthcare); Lymphedema; Psychological intervention; Physical therapy; International Classification of Functioning, Disability and Health; Activities of daily living; Physical medicine and rehabilitation; Nursing; Cancer; Psychiatry; Breast cancer","score_opus":0.10833315536884193,"score_gpt":0.4519321452570108,"score_spread":0.3435989898881689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066277295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037331365,0.95874196,0.0000048723655,0.00021677138,0.00019463916,0.0033061455,0.00010911579,0.000025149793,0.00007000819],"genre_scores_gemma":[0.0051174513,0.9897389,0.0026335893,0.000006139414,0.00004306077,0.0014826226,0.00091595895,0.00003762283,0.000024674848],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99718225,0.00047278832,0.0011650304,0.0006431353,0.00023397368,0.00030283027],"domain_scores_gemma":[0.9977248,0.0011167425,0.00044598553,0.00046848052,0.00009751648,0.0001464853],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002386398,0.00049934594,0.0026603928,0.0006631619,0.000044232263,0.000009112527,0.00007628677,0.00030900966,0.000046940928],"category_scores_gemma":[0.00025955736,0.00034477457,0.00020472461,0.000464859,0.00022394017,0.00006862482,0.000047560552,0.00025599575,0.000018935007],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010321276,0.012249891,0.26261467,0.0041222633,0.00014077102,0.000012058619,0.0002174643,0.0000028299755,1.5951713e-8,0.00059270207,0.000011549011,0.7199326],"study_design_scores_gemma":[0.012250684,0.004993154,0.33819625,0.015801683,0.0011019773,0.000009260514,0.00007073707,8.631082e-7,2.3534376e-7,0.00011841355,0.6271249,0.00033182968],"about_ca_topic_score_codex":0.0002956048,"about_ca_topic_score_gemma":0.00040488492,"teacher_disagreement_score":0.71960074,"about_ca_system_score_codex":0.002899468,"about_ca_system_score_gemma":0.0008097745,"threshold_uncertainty_score":0.9999004},"labels":[],"label_agreement":null},{"id":"W2084667136","doi":"10.1007/s11864-006-0002-0","title":"Should finasteride be used to prevent prostate cancer?","year":2006,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Finasteride; Prostate cancer; Dutasteride; Prostate; Internal medicine; Cancer; Regimen; Placebo; Prostate biopsy; Urology; Gynecology; Oncology; Pathology; Alternative medicine","score_opus":0.2566947204762712,"score_gpt":0.4982076700975717,"score_spread":0.24151294962130054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084667136","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007819417,0.98518026,0.0000050061462,0.001947644,0.001654097,0.00854363,0.0013173909,0.00009556231,0.00047448746],"genre_scores_gemma":[0.000044382632,0.96571565,0.00038245216,0.00008300049,0.00038762245,0.028943492,0.002445623,0.000101925754,0.0018958837],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99639994,0.00024800192,0.0011869648,0.0011136001,0.00028367803,0.00076781894],"domain_scores_gemma":[0.9982077,0.0002432306,0.0003784169,0.00073985977,0.00008689362,0.00034389115],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015488012,0.0009127483,0.0031153038,0.0007129248,0.000100975965,0.00003453538,0.00017384283,0.00037207335,0.00019031753],"category_scores_gemma":[0.000023729006,0.00066847965,0.000715639,0.00071591965,0.00009072505,0.00006042608,0.00012313135,0.00041707463,0.00015441749],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005146625,0.008201052,0.0005270815,0.0032453255,0.00043703782,0.0002553803,0.0002366139,0.00005082215,3.2877347e-7,0.00010177865,0.005589021,0.9813041],"study_design_scores_gemma":[0.0023781094,0.0032961573,0.00021729791,0.012868772,0.003049951,0.00007041911,0.000018770845,0.0000041935386,0.0000071096324,0.00001785732,0.97762346,0.0004478854],"about_ca_topic_score_codex":0.0003081978,"about_ca_topic_score_gemma":0.0013233575,"teacher_disagreement_score":0.9808562,"about_ca_system_score_codex":0.012226908,"about_ca_system_score_gemma":0.0024212103,"threshold_uncertainty_score":0.9995766},"labels":[],"label_agreement":null},{"id":"W2087083130","doi":"10.1007/s11864-004-0021-7","title":"Primary thyroid lymphomas","year":2004,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Thyroid lymphoma; Vincristine; Thyroid; Lymphoma; Radiation therapy; Pathology; Prednisone; Cyclophosphamide; Rituximab; MALT lymphoma; Chemotherapy; Oncology; Internal medicine; Thyroiditis","score_opus":0.11380103128319352,"score_gpt":0.4442673289081999,"score_spread":0.3304662976250064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087083130","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004268248,0.98970675,0.000005727584,0.00017374461,0.0015548635,0.0031453846,0.00018216044,0.00012177982,0.005066892],"genre_scores_gemma":[0.00002464799,0.9902361,0.0007308814,0.00003439273,0.00041901675,0.005693514,0.0022241923,0.000091262584,0.00054597575],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970807,0.00014648368,0.0010009559,0.0009373574,0.00023267564,0.0006018264],"domain_scores_gemma":[0.99824244,0.00027506234,0.00035334035,0.0008105737,0.00005302515,0.00026555362],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011373154,0.00083709206,0.0033084557,0.000703886,0.00009905912,0.00001957948,0.00017184306,0.00052898575,0.00024004669],"category_scores_gemma":[0.00002055155,0.0006002584,0.0010768975,0.00058816356,0.00015402817,0.000056340366,0.000087712164,0.00039379008,0.0006861766],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003171651,0.009464599,0.000104896026,0.0051265555,0.0005579963,0.00042482413,0.00007015324,0.000005013494,8.3106e-8,0.0018764152,0.0006098038,0.98172796],"study_design_scores_gemma":[0.006060488,0.0028081648,0.00019622053,0.015478948,0.0040699807,0.00055566203,0.000011358992,4.8193925e-7,4.772657e-7,0.00014847235,0.97029465,0.0003750646],"about_ca_topic_score_codex":0.000053749296,"about_ca_topic_score_gemma":0.000056131856,"teacher_disagreement_score":0.98135287,"about_ca_system_score_codex":0.026329938,"about_ca_system_score_gemma":0.0052150283,"threshold_uncertainty_score":0.9996449},"labels":[],"label_agreement":null},{"id":"W2088453201","doi":"10.1007/s11864-008-0063-3","title":"Acupuncture as an Evidence-Based Option for Symptom Control in Cancer Patients","year":2008,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Acupuncture Treatment Research Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Clinical Oncology Group","funders":"","keywords":"Medicine; Acupuncture; Nausea; Randomized controlled trial; Clinical trial; Vomiting; Central nervous system; Physical therapy; Physical medicine and rehabilitation; Intensive care medicine; Anesthesia; Alternative medicine; Surgery; Internal medicine; Pathology","score_opus":0.23841671953166124,"score_gpt":0.5383749176735155,"score_spread":0.2999581981418543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088453201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012654886,0.98122627,0.00007077493,0.0005569084,0.0009351786,0.015345323,0.00046247756,0.00007903797,0.00005852039],"genre_scores_gemma":[0.00082153664,0.963541,0.0004705558,0.00008309464,0.0004033726,0.03145491,0.0029409456,0.00008142795,0.00020320316],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99576515,0.0006744982,0.001091233,0.0011745275,0.00044161687,0.0008529862],"domain_scores_gemma":[0.99616766,0.0021454697,0.00043581118,0.0006312437,0.00033919423,0.00028061165],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.000211114,0.0013105499,0.00431008,0.0012576199,0.00018111321,0.000022228105,0.0002386217,0.0007168196,0.00010394148],"category_scores_gemma":[0.00051477645,0.0006540436,0.0010250047,0.0006902575,0.00025393465,0.00020353995,0.000050914834,0.00061624113,0.00005983754],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060257444,0.009988498,0.0067651486,0.0034164141,0.00063035946,0.00009973076,0.00016557188,0.00005643992,2.5299252e-7,0.00008495289,0.00086225447,0.9773278],"study_design_scores_gemma":[0.012711581,0.009352999,0.0020520138,0.016227888,0.0031025405,0.00003692198,0.000019396168,0.0001459322,6.2717925e-7,0.00003479997,0.9558695,0.00044582802],"about_ca_topic_score_codex":0.00015918074,"about_ca_topic_score_gemma":0.0005702948,"teacher_disagreement_score":0.976882,"about_ca_system_score_codex":0.014394981,"about_ca_system_score_gemma":0.0035924022,"threshold_uncertainty_score":0.9999646},"labels":[],"label_agreement":null},{"id":"W2089360403","doi":"10.1007/s11864-015-0335-7","title":"Soft Tissue Sarcoma and Radiation Therapy Advances, Impact on Toxicity","year":2015,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Radiation therapy; Image-guided radiation therapy; Pazopanib; Soft tissue sarcoma; Clinical trial; Soft tissue; Sarcoma; Radiology; Oncology; Cancer; Internal medicine; Pathology","score_opus":0.1342204740566365,"score_gpt":0.4882577170840611,"score_spread":0.3540372430274246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089360403","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017998735,0.9937078,0.0000035254081,0.00015061873,0.00064391707,0.0030092215,0.00019531521,0.000057801637,0.00043193603],"genre_scores_gemma":[0.00046455747,0.9956987,0.00017965827,0.000025102801,0.0003166759,0.0019578813,0.0012504656,0.00005057715,0.00005639649],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99779266,0.0003512686,0.000604571,0.00066126214,0.000201938,0.00038831335],"domain_scores_gemma":[0.9983946,0.0005029858,0.000288967,0.0004839455,0.000058236223,0.00027126583],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018411501,0.0006698719,0.00226295,0.00054523174,0.0000793922,0.00002210669,0.00008662042,0.0003608932,0.000108565706],"category_scores_gemma":[0.000038969898,0.0004137698,0.00037360028,0.0003428713,0.00009942067,0.00007547181,0.000032003747,0.00030756588,0.00014212291],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009056135,0.0075146668,0.0016809058,0.0003638792,0.00030761375,0.00011284305,0.0000705862,0.000004611242,9.123092e-8,0.00012551341,0.00056357984,0.9891651],"study_design_scores_gemma":[0.004533035,0.0069755763,0.0014294886,0.002084757,0.00085667236,0.00023949302,0.000009651025,0.0000072680787,0.0000017415472,0.00006295278,0.983535,0.00026437367],"about_ca_topic_score_codex":0.000031099826,"about_ca_topic_score_gemma":0.000027902455,"teacher_disagreement_score":0.9889008,"about_ca_system_score_codex":0.0053742165,"about_ca_system_score_gemma":0.0008900178,"threshold_uncertainty_score":0.99983144},"labels":[],"label_agreement":null},{"id":"W2091163157","doi":"10.1007/s11864-001-0017-5","title":"Limited stage small cell lung cancer","year":2001,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Etoposide; Radiation therapy; Prophylactic cranial irradiation; Chemotherapy; Oncology; Stage (stratigraphy); Cisplatin; Lung cancer; Internal medicine; Surgery; Conventional PCI","score_opus":0.23981062934101902,"score_gpt":0.5337653040662865,"score_spread":0.2939546747252675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091163157","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000081219696,0.986709,0.000014143592,0.00025292445,0.0013767071,0.0044116164,0.0003284202,0.00009787705,0.0067280955],"genre_scores_gemma":[0.0000031714608,0.9762538,0.00027161866,0.000017760181,0.00055928365,0.00825985,0.0006847352,0.00007595111,0.013873835],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99700415,0.00037214247,0.00079145294,0.0008112096,0.00024441033,0.0007766587],"domain_scores_gemma":[0.9982161,0.00046147054,0.00029613517,0.00065193605,0.00013046658,0.00024392208],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018760723,0.0006613943,0.0026809932,0.00087040896,0.00012325251,0.000019266075,0.0002177417,0.00039400955,0.0006647631],"category_scores_gemma":[0.00006758837,0.00047562903,0.00059101934,0.0010113738,0.00017683535,0.000038546925,0.00017336328,0.0008145511,0.00013896539],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003668667,0.0027611197,0.001109627,0.012759492,0.0006373786,0.0003190185,0.00015672634,0.000008992099,1.5336077e-7,0.00005853427,0.0038267483,0.97832555],"study_design_scores_gemma":[0.0026563879,0.0009471934,0.000083959014,0.009337375,0.0031145453,0.00004038464,0.000044296707,0.000032029166,3.592343e-7,0.0000026396733,0.9834336,0.00030719923],"about_ca_topic_score_codex":0.00023917248,"about_ca_topic_score_gemma":0.00074225164,"teacher_disagreement_score":0.97960687,"about_ca_system_score_codex":0.014077319,"about_ca_system_score_gemma":0.0033892929,"threshold_uncertainty_score":0.99976957},"labels":[],"label_agreement":null},{"id":"W2121455177","doi":"10.1007/s11864-010-0136-y","title":"Gastric Cancer Surgery: An American Perspective on the Current Options and Standards","year":2011,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Georgetown Hospital","funders":"","keywords":"Medicine; Cancer; Lymphadenectomy; Population; Gastrectomy; General surgery; Surgery; Disease; Natural history; Stage (stratigraphy); Internal medicine","score_opus":0.18272436065326786,"score_gpt":0.48515096498500315,"score_spread":0.3024266043317353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121455177","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022671602,0.9931553,0.00002601857,0.0007799432,0.0015213524,0.0023800682,0.00044967348,0.00006625688,0.001394642],"genre_scores_gemma":[0.00015792894,0.99585825,0.000090964204,0.00003397296,0.0004357057,0.0029479675,0.00020740018,0.00004904158,0.00021879203],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972365,0.0004914916,0.00067235733,0.0007687643,0.00033293804,0.000497961],"domain_scores_gemma":[0.9979136,0.0005795563,0.00047339467,0.0006029097,0.00022319143,0.00020735578],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052664033,0.00060886453,0.0020740961,0.0010318473,0.00019111097,0.000035043016,0.00016799525,0.00010526554,0.0003000016],"category_scores_gemma":[0.00014431258,0.00036989502,0.0005041583,0.001053388,0.00041774273,0.000065781154,0.00008784841,0.0006644128,0.000027759805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055667908,0.001633665,0.0008038735,0.0004955062,0.00033775513,0.000015924632,0.0002724543,0.0000015068869,4.1495523e-9,0.006413697,0.00285135,0.9871186],"study_design_scores_gemma":[0.0007072608,0.001323077,0.0018861934,0.0029356296,0.0027054255,0.000029581324,0.00034038586,0.000006637666,1.7539914e-8,0.000086070264,0.9897168,0.00026290413],"about_ca_topic_score_codex":0.00043015467,"about_ca_topic_score_gemma":0.0007987803,"teacher_disagreement_score":0.98686546,"about_ca_system_score_codex":0.010441884,"about_ca_system_score_gemma":0.0024217032,"threshold_uncertainty_score":0.9998753},"labels":[],"label_agreement":null},{"id":"W2266388176","doi":"10.1007/s11864-015-0383-z","title":"Health-Related Quality of Life After Spine Surgery for Primary Bone Tumour","year":2016,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; Centre Hospitalier Universitaire de Sherbrooke; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Sacrum; Surgery; Adverse effect; Quality of life (healthcare); Chordoma; Referral; General surgery; Internal medicine","score_opus":0.1828155753395027,"score_gpt":0.4626293385484711,"score_spread":0.2798137632089684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2266388176","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019415,0.99030983,0.000017965634,0.0009869022,0.0012216662,0.0044103917,0.00093572325,0.00005407773,0.000121929355],"genre_scores_gemma":[0.00088743755,0.9881113,0.00049626426,0.00003868157,0.00018623871,0.007260197,0.0024834694,0.00007667972,0.00045971212],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948735,0.00062284735,0.0029623352,0.0007468663,0.00021013657,0.0005843083],"domain_scores_gemma":[0.9959571,0.0014823322,0.0015017167,0.0006125922,0.00012293567,0.00032336148],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00072775566,0.0006586532,0.006770648,0.0007376349,0.00006797055,0.0000062140166,0.00008687242,0.00038144473,0.00016506531],"category_scores_gemma":[0.00026081316,0.00042894218,0.0015971429,0.0003874413,0.0001809011,0.000054065586,0.00005951104,0.0002458814,0.00009291604],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020366971,0.009495505,0.0025682054,0.013684494,0.0007271536,0.000051199593,0.000032683474,1.2118926e-7,1.6331703e-7,0.00027314704,0.0009704482,0.9719932],"study_design_scores_gemma":[0.0054009208,0.0018315425,0.019936394,0.02291786,0.0014356239,0.000093926974,0.0000059512895,4.2944967e-7,2.7071206e-7,0.00006936471,0.94797486,0.00033286316],"about_ca_topic_score_codex":0.00007293728,"about_ca_topic_score_gemma":0.00007447173,"teacher_disagreement_score":0.9716603,"about_ca_system_score_codex":0.004012704,"about_ca_system_score_gemma":0.0036152925,"threshold_uncertainty_score":0.99981624},"labels":[],"label_agreement":null},{"id":"W2277678255","doi":"10.1007/s11864-015-0381-1","title":"Molecular Predictors of Radiotherapy Response in Sarcoma","year":2015,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Radiation therapy; Medicine; Sarcoma; Soft tissue sarcoma; Pathology; Cancer; Pathological; Soft tissue; Oncology; Internal medicine","score_opus":0.1218713074569151,"score_gpt":0.4591788035450592,"score_spread":0.3373074960881441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277678255","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015570474,0.98036444,0.000004694767,0.00014928736,0.00066293264,0.0028730573,0.00012277004,0.0000321032,0.0002202413],"genre_scores_gemma":[0.00073005905,0.99573493,0.00056910963,0.00000987113,0.00008682749,0.002341087,0.00042225714,0.000060989874,0.00004485829],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966018,0.0010358655,0.0011325917,0.0005882396,0.00024707912,0.0003943971],"domain_scores_gemma":[0.9980577,0.00063866586,0.00035206554,0.00069072226,0.0000735352,0.00018731758],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004844564,0.0005614113,0.0031374085,0.0013353599,0.000019447853,0.000006161699,0.00015587064,0.00044525682,0.00006362115],"category_scores_gemma":[0.00009604342,0.00041323417,0.0006218902,0.0007743303,0.00015306774,0.00003272921,0.000045309585,0.0003272305,0.000031159387],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052215846,0.012804549,0.0050583105,0.0009937577,0.0005226228,0.00084174686,0.00022898638,0.000016798056,0.0000010361897,0.0001591771,0.00020790413,0.97864294],"study_design_scores_gemma":[0.0064582517,0.004430085,0.0017824196,0.0058304532,0.0013820291,0.00021378578,0.00003438191,0.000011684072,0.0000024336136,0.000022478273,0.9796072,0.00022474362],"about_ca_topic_score_codex":0.00003943235,"about_ca_topic_score_gemma":0.000031046122,"teacher_disagreement_score":0.9793993,"about_ca_system_score_codex":0.006949927,"about_ca_system_score_gemma":0.002147085,"threshold_uncertainty_score":0.999832},"labels":[],"label_agreement":null},{"id":"W2342232619","doi":"10.1007/s11864-016-0407-3","title":"SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?","year":2016,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; SABR volatility model; Lung cancer; Resection; Cancer; Oncology; Lung; Internal medicine; Surgery","score_opus":0.12307388796009591,"score_gpt":0.46414019256516215,"score_spread":0.34106630460506626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342232619","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00095534686,0.9816309,0.00009906347,0.0019717752,0.003776012,0.010066332,0.0011127129,0.00009229621,0.00029554407],"genre_scores_gemma":[0.00011655272,0.9622885,0.0007946066,0.00006356966,0.001380204,0.032907594,0.0011523343,0.00011990126,0.001176739],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967251,0.00023726026,0.00090878777,0.0012429258,0.00018048864,0.00070547365],"domain_scores_gemma":[0.9976005,0.000458752,0.00046562136,0.00085470325,0.00020221087,0.00041818825],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001787663,0.00080226926,0.002546647,0.00084625796,0.00016763147,0.00003115336,0.00020314312,0.0005759877,0.00015693302],"category_scores_gemma":[0.000026306661,0.0005379244,0.00073242537,0.0005413951,0.000056842888,0.00008031548,0.00006709603,0.0002958132,0.00008761571],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003604584,0.006392041,0.002397907,0.00816157,0.0006012867,0.00004606417,0.00022515623,0.000011838439,6.007928e-7,0.00005744095,0.010263476,0.97148216],"study_design_scores_gemma":[0.005652105,0.007379813,0.00037215886,0.027796905,0.0044405903,0.000021869459,0.00003879142,0.000028266946,0.00001067076,0.00001215919,0.9538082,0.00043850986],"about_ca_topic_score_codex":0.000106462125,"about_ca_topic_score_gemma":0.0023498232,"teacher_disagreement_score":0.97104365,"about_ca_system_score_codex":0.015963007,"about_ca_system_score_gemma":0.001670366,"threshold_uncertainty_score":0.9997072},"labels":[],"label_agreement":null},{"id":"W2618230854","doi":"10.1007/s11864-017-0484-y","title":"Overview of the 8th Edition TNM Classification for Head and Neck Cancer","year":2017,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":687,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Head and neck cancer; Stage (stratigraphy); Cancer; Oncology; Head and neck; Merkel cell carcinoma; Internal medicine; Sarcoma; Skin cancer; Cancer staging; Carcinoma; Pathology; Surgery","score_opus":0.5632878262471015,"score_gpt":0.5804980947292319,"score_spread":0.017210268482130364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618230854","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015735651,0.9935949,0.0000059644617,0.0008442719,0.0020046139,0.0025612283,0.00032902436,0.000010279721,0.0004923862],"genre_scores_gemma":[0.00008612828,0.99444634,0.00012079504,0.000013341987,0.00044354115,0.0043816646,0.00019968567,0.000017278855,0.0002912174],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884987,0.000101428566,0.0004732052,0.0003140088,0.00008486553,0.00017665212],"domain_scores_gemma":[0.9988508,0.00018227263,0.00043618982,0.00040195565,0.0000826042,0.000046148114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000119580916,0.00023920322,0.0015386369,0.00012347233,0.00016361316,0.000006486905,0.00009201063,0.00019508648,0.000018044802],"category_scores_gemma":[0.00006908904,0.00013946985,0.00031106328,0.0001132328,0.00017558035,0.000033542474,0.00004387729,0.00015835575,0.0000031273853],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018440189,0.0006053647,0.00034815623,0.006709705,0.00014699293,5.601928e-7,0.00007501914,1.2482747e-7,2.4701978e-7,0.00079688313,0.0014455977,0.9898529],"study_design_scores_gemma":[0.0015747892,0.00076601055,0.004249814,0.018163504,0.0016568935,0.000012011806,0.0000138237965,0.000010827545,3.993498e-7,0.00005335763,0.9734036,0.0000949781],"about_ca_topic_score_codex":0.000045632154,"about_ca_topic_score_gemma":0.00046106626,"teacher_disagreement_score":0.98975796,"about_ca_system_score_codex":0.0013230763,"about_ca_system_score_gemma":0.0009819785,"threshold_uncertainty_score":0.56874156},"labels":[],"label_agreement":null},{"id":"W2618749156","doi":"10.1007/s11864-017-0482-0","title":"The Cisplatin Total Dose and Concomitant Radiation in Locoregionally Advanced Head and Neck Cancer: Any Recent Evidence for Dose Efficacy?","year":2017,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Head and neck cancer; Regimen; Radiation therapy; Clinical trial; Chemoradiotherapy; Oncology; Concomitant; Cisplatin; Cumulative dose; Randomized controlled trial; Intensive care medicine; Internal medicine; Chemotherapy","score_opus":0.3261756068688651,"score_gpt":0.538794438171456,"score_spread":0.2126188313025909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618749156","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072546336,0.9846003,0.0000031215814,0.0020419084,0.0010340858,0.0048659598,0.00011048528,0.00001703402,0.000072458875],"genre_scores_gemma":[0.0005134171,0.9932294,0.00028928785,0.000018759196,0.00023133135,0.005445849,0.000109187764,0.000026054762,0.00013673835],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979308,0.00018975283,0.0007393238,0.0006098199,0.00012561033,0.00040465486],"domain_scores_gemma":[0.9969312,0.0020545751,0.0004171282,0.00037713972,0.000085771164,0.00013418036],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000345467,0.00041775015,0.0018192413,0.0001943944,0.00033577267,0.0000331954,0.000105306266,0.00022094723,0.0000062515774],"category_scores_gemma":[0.00049085653,0.00026715023,0.00016685507,0.00016379703,0.00031384776,0.00008888846,0.00007832808,0.0003078761,0.000002827279],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049273163,0.0005212189,0.0012051912,0.0013120526,0.0001354599,0.000018440634,0.00024043806,0.000004002865,4.6769247e-7,0.00020437333,0.00019051641,0.9956751],"study_design_scores_gemma":[0.008134299,0.0024503947,0.02404907,0.016687531,0.00063518283,0.00006308149,0.00003527091,0.00007537868,1.4722721e-7,0.000028326398,0.9476262,0.00021512625],"about_ca_topic_score_codex":0.00006503559,"about_ca_topic_score_gemma":0.0017208529,"teacher_disagreement_score":0.99546,"about_ca_system_score_codex":0.0025830164,"about_ca_system_score_gemma":0.0014769806,"threshold_uncertainty_score":0.99997807},"labels":[],"label_agreement":null},{"id":"W2765940870","doi":"10.1007/s11864-017-0508-7","title":"Optimal Therapies for Newly Diagnosed Elderly Patients with Glioblastoma","year":2017,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; St. Michael's Hospital; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Accuray; Elekta; Brain Tumour Research; Varian Medical Systems; Medtronic","keywords":"Medicine; Contraindication; Radiation therapy; Glioblastoma; Temozolomide; Chemotherapy; Oncology; Internal medicine; Adjuvant; Surgery; Pathology; Alternative medicine","score_opus":0.10900599538897555,"score_gpt":0.4289440688693058,"score_spread":0.31993807348033027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765940870","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056865388,0.9846042,0.000023292414,0.00014952615,0.0009132342,0.007850682,0.0005393051,0.0000724305,0.0001608331],"genre_scores_gemma":[0.00043139106,0.9806114,0.0018672379,0.000008519587,0.00026588046,0.014595374,0.0019953386,0.000105503175,0.00011937677],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973467,0.00015299986,0.00076836825,0.0008847852,0.00022555763,0.0006215953],"domain_scores_gemma":[0.9973308,0.0006743935,0.00064278406,0.00094039325,0.00018818643,0.0002234695],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001075511,0.0008726892,0.0029843673,0.0006721223,0.00028096873,0.00006708783,0.00024022529,0.00043993627,0.00007381327],"category_scores_gemma":[0.000072845316,0.0005421192,0.00081227353,0.00021740094,0.00020669865,0.00010138371,0.000054197153,0.0002734641,0.00007484065],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022935502,0.01275764,0.0020277146,0.0014016554,0.001259588,0.0001250288,0.000127045,0.000007195846,2.0993236e-8,0.00015770957,0.0005603138,0.9813467],"study_design_scores_gemma":[0.016705252,0.016724234,0.0013501908,0.0065982915,0.0045792223,0.00003338168,0.00002517306,0.000005805721,4.6943623e-7,0.000011040833,0.95356303,0.00040387516],"about_ca_topic_score_codex":0.000019490044,"about_ca_topic_score_gemma":0.00019848037,"teacher_disagreement_score":0.98094285,"about_ca_system_score_codex":0.0023194223,"about_ca_system_score_gemma":0.0010040285,"threshold_uncertainty_score":0.99970305},"labels":[],"label_agreement":null},{"id":"W2769777633","doi":"10.1007/s11864-017-0516-7","title":"Combined Vertebral Augmentation and Radiofrequency Ablation in the Management of Spinal Metastases: an Update","year":2017,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Radiofrequency ablation; Radiosurgery; Surgery; Percutaneous; Radiation therapy; Metastasis; Quality of life (healthcare); Radiology; Cancer; Ablation; Internal medicine","score_opus":0.2386865697659212,"score_gpt":0.508018577923553,"score_spread":0.2693320081576318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769777633","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012640504,0.9924888,0.0000958916,0.00021575403,0.00039080164,0.0046718824,0.000114417635,0.00001745132,0.00074097805],"genre_scores_gemma":[0.00110908,0.99239004,0.0024002513,0.000018716713,0.000036503032,0.0014016253,0.0025650423,0.000022875762,0.000055858112],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973156,0.0006969927,0.00094129425,0.0005046077,0.00027697068,0.00026453086],"domain_scores_gemma":[0.99842113,0.000074164076,0.0005949997,0.0007853565,0.000034581954,0.000089753485],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007552775,0.00039191963,0.0014296528,0.00065827294,0.00008923988,0.00003456899,0.0002494331,0.00010718808,0.00007897391],"category_scores_gemma":[0.000020962148,0.00027214488,0.00021706361,0.00028054323,0.00016810569,0.00018725684,0.00006359923,0.00021275942,0.000017852897],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000133895,0.003697505,0.00016986439,0.007147145,0.0004694241,0.00019553327,0.00013200128,0.000003397691,4.8612108e-8,0.008535169,0.000061025035,0.979455],"study_design_scores_gemma":[0.010469517,0.0036228548,0.005390416,0.008776813,0.011750781,0.00005471076,0.00050406554,0.00022011591,1.305285e-7,0.0007288187,0.9581472,0.00033453727],"about_ca_topic_score_codex":0.00003556058,"about_ca_topic_score_gemma":0.000031300966,"teacher_disagreement_score":0.97912043,"about_ca_system_score_codex":0.00080255663,"about_ca_system_score_gemma":0.00025378112,"threshold_uncertainty_score":0.99997306},"labels":[],"label_agreement":null},{"id":"W2791438625","doi":"10.1007/s11864-018-0532-2","title":"When to Stop Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia","year":2018,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Nilotinib; Chronic myelogenous leukemia; Dasatinib; Oncology; Internal medicine; Tyrosine-kinase inhibitor; Imatinib mesylate; Myeloid leukemia; Clinical trial; Clinical endpoint; Intensive care medicine; Imatinib; Leukemia; Cancer","score_opus":0.10711034678265129,"score_gpt":0.4213271519235706,"score_spread":0.3142168051409193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791438625","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006220334,0.9816106,0.00010920693,0.00036155494,0.002972287,0.013343309,0.00069175457,0.00008228483,0.00020699644],"genre_scores_gemma":[0.00007194663,0.9779155,0.001542186,0.000017951921,0.002085069,0.014385913,0.0016257705,0.00014912804,0.0022065225],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955264,0.0002780403,0.0016992025,0.0012454888,0.00032054403,0.0009303471],"domain_scores_gemma":[0.99569637,0.0013925856,0.00069477776,0.0016666526,0.0002077091,0.00034190042],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002631742,0.001208549,0.003751057,0.0008649413,0.0002209198,0.000023442337,0.0003738789,0.00064108503,0.00026023178],"category_scores_gemma":[0.000111796944,0.0007258233,0.0015098801,0.0007386094,0.00039679385,0.00005918293,0.0001030074,0.0002861624,0.00029981454],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00020401888,0.006122129,0.000031290758,0.0027612343,0.001340722,0.000041965326,0.0006709014,0.000027052325,0.0000025999914,0.00016567626,0.004301387,0.984331],"study_design_scores_gemma":[0.009627361,0.022039616,0.00003083446,0.006626068,0.007338537,0.00011810985,0.000054315802,0.00008272471,0.00003875759,0.000026483398,0.9535869,0.00043032496],"about_ca_topic_score_codex":0.00024243855,"about_ca_topic_score_gemma":0.0006048897,"teacher_disagreement_score":0.9839007,"about_ca_system_score_codex":0.07760677,"about_ca_system_score_gemma":0.008900765,"threshold_uncertainty_score":0.9995193},"labels":[],"label_agreement":null},{"id":"W2851342260","doi":"10.1007/s11864-018-0554-9","title":"Head and Neck Cancer Survivorship Care: A Review of the Current Guidelines and Remaining Unmet Needs","year":2018,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Cancer Australia","keywords":"Medicine; Survivorship curve; Multidisciplinary approach; Quality of life (healthcare); Family medicine; Head and neck cancer; Cancer survivorship; Disease; Health care; Head and neck; Cancer; MEDLINE; Gerontology; Nursing; Surgery; Internal medicine","score_opus":0.2986488952729773,"score_gpt":0.532532651582271,"score_spread":0.23388375630929376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2851342260","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00056587043,0.99358404,0.0000011265291,0.0011101856,0.0020094889,0.002143469,0.00015320868,0.00001878236,0.0004138453],"genre_scores_gemma":[0.000021704374,0.99773836,0.00021949608,0.000079427744,0.00046409178,0.0012710221,0.00009090556,0.000030578754,0.00008443085],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975153,0.00040199177,0.0011121004,0.00046951463,0.00018107852,0.00032002118],"domain_scores_gemma":[0.99839044,0.00029418626,0.0004498211,0.00046628903,0.00028365993,0.00011559765],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037594116,0.0004760585,0.0028923757,0.00027690828,0.00012818612,0.000006853286,0.00011972673,0.00016513721,0.000025346977],"category_scores_gemma":[0.0002867646,0.00027030584,0.000333291,0.0006890066,0.00035610824,0.000028513163,0.00018328724,0.00037080937,0.0000036927345],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011427409,0.00023250011,0.0015314482,0.0650971,0.00016658635,0.0000023440289,0.00041950122,6.019417e-8,2.3691795e-8,0.00009991517,0.0021414391,0.9302977],"study_design_scores_gemma":[0.0008048132,0.0006678112,0.00029715977,0.23227735,0.0021047276,0.000037496495,0.000051892614,0.0000013596954,1.0432031e-7,0.000008207745,0.7635977,0.0001513628],"about_ca_topic_score_codex":0.00017227443,"about_ca_topic_score_gemma":0.001282664,"teacher_disagreement_score":0.9301463,"about_ca_system_score_codex":0.0011533154,"about_ca_system_score_gemma":0.0014235664,"threshold_uncertainty_score":0.9999749},"labels":[],"label_agreement":null},{"id":"W2890928464","doi":"10.1007/s11864-018-0569-2","title":"Central Nervous System Prophylaxis Strategies in Diffuse Large B Cell Lymphoma","year":2018,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Methotrexate; Diffuse large B-cell lymphoma; Chemotherapy; Internal medicine; Oncology; Lymphoma; Central nervous system; CHOP","score_opus":0.06791264979052666,"score_gpt":0.39285534009087036,"score_spread":0.32494269030034373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890928464","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009978001,0.9809261,0.00000996382,0.000027516415,0.0020191816,0.0044800937,0.0003609486,0.00013481021,0.0020633594],"genre_scores_gemma":[0.016866641,0.9758134,0.0002406429,0.0000057874026,0.00051730726,0.0048470264,0.0013982048,0.000097637145,0.00021335825],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955175,0.00053167256,0.0014154809,0.0011370383,0.00026905822,0.0011292505],"domain_scores_gemma":[0.9979232,0.00032874607,0.00046141163,0.00090125273,0.00007664796,0.00030872485],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001927626,0.0010106389,0.0033714664,0.0010332005,0.00012549474,0.00006562237,0.00023429435,0.00074710156,0.00006359657],"category_scores_gemma":[0.000024813342,0.0007241422,0.00087460055,0.00081409357,0.00016238462,0.00010116079,0.00012408213,0.0002837715,0.0003891171],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005267573,0.065212116,0.0009655379,0.008529116,0.00026267656,0.0010394162,0.00031796462,0.0000018281852,5.6793805e-8,0.0011534002,0.00027059484,0.9221946],"study_design_scores_gemma":[0.019494554,0.0038769427,0.002802753,0.012070202,0.0018626808,0.00043651683,0.00047990558,0.00003826747,9.605774e-7,0.000011477372,0.9584321,0.00049363566],"about_ca_topic_score_codex":0.00020374321,"about_ca_topic_score_gemma":0.0007568711,"teacher_disagreement_score":0.95816153,"about_ca_system_score_codex":0.018113168,"about_ca_system_score_gemma":0.0033051784,"threshold_uncertainty_score":0.99952096},"labels":[],"label_agreement":null},{"id":"W2917387482","doi":"10.1007/s11864-019-0617-6","title":"The Role of Angiogenesis Inhibitors in the Era of Immune Checkpoint Inhibitors and Targeted Therapy in Metastatic Non-Small Cell Lung Cancer","year":2019,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Bristol-Myers Squibb","keywords":"Medicine; Bevacizumab; Oncology; Lung cancer; Atezolizumab; Anaplastic lymphoma kinase; Internal medicine; Population; Combination therapy; Targeted therapy; Chemotherapy; Maintenance therapy; Epidermal growth factor receptor; Immunotherapy; Cancer; Pembrolizumab; Cancer research","score_opus":0.04126358621587533,"score_gpt":0.4020381611712739,"score_spread":0.36077457495539855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917387482","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055025384,0.9394503,0.0000012264549,0.00015358155,0.0004857712,0.0045643137,0.0001326007,0.0000056777585,0.0001810975],"genre_scores_gemma":[0.025133014,0.97102284,0.00014016323,0.000005616907,0.000056622182,0.0033345402,0.00022675168,0.000034415803,0.00004603015],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99739504,0.00041963102,0.0013097922,0.0003889578,0.00016431775,0.00032227015],"domain_scores_gemma":[0.9981953,0.0005947313,0.0006393686,0.00045260543,0.00007196019,0.00004605585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003951602,0.00041929263,0.0016728893,0.0004527212,0.00006190272,0.000010542351,0.00016522706,0.00017330603,0.000018160255],"category_scores_gemma":[0.000020885043,0.00021924957,0.00046291752,0.00081406574,0.0001611007,0.00004094899,0.000045460714,0.0003385908,0.0000022874133],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057898767,0.0028391008,0.008881113,0.0017858457,0.0005516176,0.000011660552,0.0030798619,0.0000503267,0.000031650776,0.000048384278,0.000019206002,0.9826433],"study_design_scores_gemma":[0.0183342,0.0045640003,0.018084373,0.02105617,0.010188546,0.000055274475,0.0050167474,0.00026167725,0.0005791487,0.00010778585,0.92099166,0.0007603897],"about_ca_topic_score_codex":0.0014780076,"about_ca_topic_score_gemma":0.0009065959,"teacher_disagreement_score":0.9818829,"about_ca_system_score_codex":0.0014761762,"about_ca_system_score_gemma":0.0016049927,"threshold_uncertainty_score":0.8940738},"labels":[],"label_agreement":null},{"id":"W2922298974","doi":"10.1007/s11864-019-0623-8","title":"Role of Bisphosphonates in Breast Cancer Therapy","year":2019,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Zoledronic acid; Bisphosphonate; Breast cancer; Osteonecrosis of the jaw; Adverse effect; Internal medicine; Oncology; Metastatic breast cancer; Adjuvant therapy; Cancer; Osteoporosis","score_opus":0.13250052695148004,"score_gpt":0.483185934135227,"score_spread":0.35068540718374697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922298974","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015109692,0.9937379,1.17768835e-7,0.00016645569,0.0007270165,0.0029096869,0.0003960718,0.000020873158,0.00053093105],"genre_scores_gemma":[0.00042578718,0.9959886,0.000083332605,0.000016240436,0.00004616452,0.0025083695,0.0005251746,0.00004375107,0.0003625694],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978753,0.00018400568,0.0008843339,0.00049751916,0.00013300037,0.0004258752],"domain_scores_gemma":[0.9988312,0.00021068605,0.00035162782,0.00042105844,0.000056364046,0.00012907568],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010062121,0.0004547753,0.0025999162,0.0006546051,0.000024782956,0.0000035138546,0.00010156794,0.00041133905,0.00030649168],"category_scores_gemma":[0.0000066360794,0.00031188925,0.00038940628,0.0005991267,0.000079676945,0.000036528876,0.000029720411,0.00035434033,0.00012447989],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001311595,0.0058872215,0.015209101,0.002264954,0.0002481994,0.000021439937,0.00009960298,0.0000023198622,2.9934841e-7,0.00011046062,0.000060014077,0.9759652],"study_design_scores_gemma":[0.0050769155,0.00091958925,0.008556496,0.007915214,0.00064318994,0.00010031232,0.000022695605,0.00000855592,9.94254e-7,0.000031659645,0.97654855,0.00017583685],"about_ca_topic_score_codex":0.0013127469,"about_ca_topic_score_gemma":0.0005681625,"teacher_disagreement_score":0.97648853,"about_ca_system_score_codex":0.0033174087,"about_ca_system_score_gemma":0.002598482,"threshold_uncertainty_score":0.9999333},"labels":[],"label_agreement":null},{"id":"W3005822748","doi":"10.1007/s11864-020-0716-4","title":"Evolving Definitions of Palliative Care: Upstream Migration or Confusion?","year":2020,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Palliative care; Medicine; CLARITY; Specialty; Nursing; End-of-life care; Intervention (counseling); Relevance (law); Health care; Confusion; Meaning (existential); Multitude; Family medicine; Psychology; Economic growth; Psychotherapist; Political science","score_opus":0.5197124836064386,"score_gpt":0.5557968442633401,"score_spread":0.03608436065690146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005822748","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017601342,0.99515367,0.00008016374,0.0001383757,0.00047824846,0.0015456947,0.00064433855,0.000033326265,0.001750173],"genre_scores_gemma":[0.00033886152,0.99284256,0.0032879105,0.0000082127,0.00015367316,0.0007463072,0.0025393039,0.000030831034,0.000052361553],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978869,0.0002694005,0.0010235184,0.0004227556,0.00017617745,0.0002212626],"domain_scores_gemma":[0.9976206,0.001054203,0.00061168964,0.00031431732,0.0002848355,0.000114371374],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000060658695,0.0004152023,0.0024432396,0.00045841944,0.000053164193,0.0000050841572,0.00011368292,0.00031921515,0.00022801179],"category_scores_gemma":[0.00038362533,0.00028909408,0.00055185484,0.00065487204,0.00017593545,0.0000410507,0.000052594267,0.0002986609,0.00004680462],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006754228,0.0015917845,0.0018599996,0.006160832,0.00045648642,0.00005739674,0.0034048047,0.0000031325353,0.0000011640824,0.0013227755,0.00036664182,0.9847074],"study_design_scores_gemma":[0.0015941787,0.0023072115,0.000119552235,0.02445437,0.0027668062,0.000010106169,0.0012180936,0.000015533913,0.000010401285,0.000051060884,0.96726555,0.00018713503],"about_ca_topic_score_codex":0.00007917216,"about_ca_topic_score_gemma":0.00038516682,"teacher_disagreement_score":0.9845203,"about_ca_system_score_codex":0.0018262503,"about_ca_system_score_gemma":0.001991749,"threshold_uncertainty_score":0.99995613},"labels":[],"label_agreement":null},{"id":"W3012199532","doi":"10.1007/s11864-020-0725-3","title":"Curative-Intent Therapies in Localized Hepatocellular Carcinoma","year":2020,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Liver transplantation; Embolization; Percutaneous; Milan criteria; Curative treatment; Cirrhosis; Radiology; Surgery; Transplantation; Ablation; Internal medicine; Disease","score_opus":0.27316647235241404,"score_gpt":0.41223359950954547,"score_spread":0.13906712715713143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012199532","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002857206,0.98918074,0.000035701578,0.0006396611,0.000712559,0.0056223143,0.00010993142,0.00010503601,0.0007368223],"genre_scores_gemma":[0.008576149,0.9836198,0.0005287422,0.000037719543,0.00022588413,0.0049606324,0.0017467741,0.000108870474,0.00019543851],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953634,0.0009787948,0.001491916,0.001163001,0.0002783792,0.00072449836],"domain_scores_gemma":[0.99817187,0.00039089055,0.00038095014,0.0006440348,0.00008109167,0.00033118748],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022873767,0.0010930339,0.0044446876,0.0010587877,0.000086754786,0.000032340424,0.00024052667,0.0006559604,0.0003432588],"category_scores_gemma":[0.00006331232,0.0008072173,0.0012507135,0.00119045,0.00021084487,0.000084766645,0.00011151014,0.00084435206,0.0004788173],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119624,0.003826464,0.0750988,0.0022768804,0.00048913585,0.0031114279,0.00077154324,2.9789828e-7,5.845704e-7,0.00040899453,0.00013643294,0.9137598],"study_design_scores_gemma":[0.0049474277,0.0024540888,0.00027917177,0.004816083,0.0021273904,0.00023208391,0.00014436184,0.000671581,0.0000035727287,0.000048519534,0.98375326,0.00052247784],"about_ca_topic_score_codex":0.00012678205,"about_ca_topic_score_gemma":0.000100597324,"teacher_disagreement_score":0.9836168,"about_ca_system_score_codex":0.005465171,"about_ca_system_score_gemma":0.0018491057,"threshold_uncertainty_score":0.99943787},"labels":[],"label_agreement":null},{"id":"W3023432596","doi":"10.1007/s11864-020-00746-8","title":"PI3K Inhibitors and Their Role as Novel Agents for Targeted Therapy in Lymphoma","year":2020,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; Jewish General Hospital","funders":"","keywords":"Idelalisib; Medicine; PI3K/AKT/mTOR pathway; Adverse effect; Lymphoma; Clinical trial; Targeted therapy; Oncology; Cancer research; Pharmacology; Immunology; Internal medicine; Cancer; Signal transduction; Chronic lymphocytic leukemia; Ibrutinib; Leukemia; Biology","score_opus":0.14918485012211347,"score_gpt":0.45621544531539787,"score_spread":0.3070305951932844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023432596","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029414773,0.9897822,0.000015148379,0.00021693211,0.00060757395,0.005862923,0.00019704446,0.00004780414,0.0003288548],"genre_scores_gemma":[0.0006075806,0.99283355,0.00028461916,0.00003827111,0.0003525121,0.004600289,0.0009922201,0.00008350552,0.00020747492],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972677,0.00021603484,0.00086835836,0.0008611419,0.00018078276,0.0006059547],"domain_scores_gemma":[0.99827754,0.0007569217,0.00021839772,0.00042555403,0.00006363438,0.00025793735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024068519,0.0006225941,0.0023395559,0.00069537567,0.00007198426,0.00002270042,0.00018951109,0.00052670256,0.00006340367],"category_scores_gemma":[0.00017193037,0.0004319945,0.00043978472,0.0006732567,0.00017945649,0.00005208206,0.00012581047,0.00030537284,0.00006160507],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00019236386,0.0030973307,0.000025350537,0.0016185661,0.00031080542,0.00008107679,0.00059095584,0.0000022386262,0.000004439401,0.0002144403,0.00028389983,0.99357855],"study_design_scores_gemma":[0.03123294,0.0033091714,0.000028634988,0.0030453373,0.00024050301,0.0003033998,0.00014597445,0.00061917846,0.000009348746,0.000081556966,0.9607106,0.00027336497],"about_ca_topic_score_codex":0.00019268978,"about_ca_topic_score_gemma":0.00010135766,"teacher_disagreement_score":0.99330515,"about_ca_system_score_codex":0.04366191,"about_ca_system_score_gemma":0.0151195675,"threshold_uncertainty_score":0.9998132},"labels":[],"label_agreement":null},{"id":"W3030067474","doi":"10.1007/s11864-020-00752-w","title":"Exercise Training for Cancer Survivors","year":2020,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cardiotoxicity; Cardiorespiratory fitness; Cancer; Rehabilitation; Survivorship curve; Cancer survivorship; Cancer therapy; Physical therapy; Intensive care medicine; Cancer treatment; Internal medicine; Chemotherapy","score_opus":0.2963883370487826,"score_gpt":0.49759753185333033,"score_spread":0.20120919480454774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030067474","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006667085,0.9934048,0.000118817916,0.0003334919,0.0013543975,0.0040194304,0.00025147345,0.00007053877,0.00038036265],"genre_scores_gemma":[0.000042756943,0.9899614,0.00069835584,0.000026422169,0.0006807348,0.007187751,0.0011076964,0.000059308324,0.0002356038],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983756,0.000107759,0.00056365336,0.00052837504,0.00010508725,0.00031952173],"domain_scores_gemma":[0.99907416,0.00026456136,0.00021258858,0.00024632033,0.00005098496,0.00015138567],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012896705,0.0004055488,0.0023338604,0.00028546804,0.00007157305,0.000011050185,0.00008503403,0.00041084446,0.000072656505],"category_scores_gemma":[0.000042091244,0.00033323411,0.00080072216,0.00037397648,0.00006522006,0.00003632147,0.000017825203,0.00031703134,0.00002591386],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003423145,0.00051769626,0.000004214227,0.0034347503,0.00026691405,0.000016354228,0.00063740107,0.0000034097766,0.0000039353286,0.00017748745,0.00015622484,0.9947474],"study_design_scores_gemma":[0.0019044844,0.0005924432,0.0000035614112,0.009619154,0.0024298362,0.000040613508,0.00010362422,0.000024118674,0.000016009513,0.000038578197,0.9850004,0.00022723479],"about_ca_topic_score_codex":0.000040489846,"about_ca_topic_score_gemma":0.0002365905,"teacher_disagreement_score":0.9945201,"about_ca_system_score_codex":0.0028036823,"about_ca_system_score_gemma":0.0017331573,"threshold_uncertainty_score":0.99991196},"labels":[],"label_agreement":null},{"id":"W3034194717","doi":"10.1007/s11864-020-00748-6","title":"Stereotactic Ablative Radiotherapy for Recurrent or Metastatic Gynecological Cancer: Extending Lives?","year":2020,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"SABR volatility model; Medicine; Radiation therapy; Ablative case; Gynecologic cancer; Endometrial cancer; Cancer; Oncology; Radiology; Internal medicine; Surgery; Ovarian cancer","score_opus":0.31633104907775855,"score_gpt":0.5337077434769574,"score_spread":0.21737669439919882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034194717","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002307528,0.9834485,0.000849677,0.00062495854,0.001916339,0.012100359,0.0006833705,0.00011034221,0.00024337544],"genre_scores_gemma":[0.0000092872015,0.9687554,0.011111948,0.000098823846,0.00029048487,0.017768975,0.0010738563,0.000103119746,0.00078810396],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99542266,0.0008807096,0.0014706523,0.001214354,0.00030009827,0.00071149814],"domain_scores_gemma":[0.995516,0.0025758117,0.00085435656,0.0005342399,0.00009660102,0.00042301643],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037308896,0.00095270213,0.004373318,0.00075487874,0.00013698838,0.00004387957,0.00027175355,0.00018831804,0.0016437311],"category_scores_gemma":[0.00057349866,0.0006321162,0.0010638286,0.00076854083,0.00017165882,0.000103771294,0.0000930657,0.0005467471,0.000078605466],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008348353,0.005574193,0.000019916568,0.008404307,0.0033097786,0.00044740867,0.0003026267,0.0000065052905,5.7795393e-8,0.0005765733,0.0011215041,0.9794023],"study_design_scores_gemma":[0.0064726137,0.00886293,0.000044594097,0.005356625,0.013134972,0.00009923253,0.0001733776,0.0004880071,7.248409e-8,0.000067051435,0.964823,0.00047750733],"about_ca_topic_score_codex":0.000007791634,"about_ca_topic_score_gemma":0.00005410013,"teacher_disagreement_score":0.9789248,"about_ca_system_score_codex":0.006751716,"about_ca_system_score_gemma":0.0022769044,"threshold_uncertainty_score":0.999613},"labels":[],"label_agreement":null},{"id":"W3128995505","doi":"10.1007/s11864-021-00817-4","title":"Immunotherapy in Neuroendocrine Neoplasms: Where Are We Now?","year":2021,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Neuroendocrine tumors; Intensive care medicine; Clinical trial; Immunotherapy; Regimen; Cancer; Lung cancer; Oncology; Internal medicine","score_opus":0.13494388790928052,"score_gpt":0.4794337252712568,"score_spread":0.3444898373619763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128995505","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017878888,0.9916132,0.0000026653104,0.002929027,0.0013616089,0.0031436563,0.00011288976,0.00008806576,0.0005700705],"genre_scores_gemma":[0.000009146255,0.99331844,0.00032672693,0.00002726771,0.00029517975,0.0033118976,0.00046174496,0.00012490946,0.0021247156],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952392,0.0009770942,0.0012774845,0.0011590498,0.00034618445,0.0010009735],"domain_scores_gemma":[0.9974628,0.00078075216,0.00040241034,0.0010160627,0.000096189615,0.0002417933],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009683,0.0008468644,0.00396419,0.0013956155,0.00007105016,0.000035254365,0.00032691823,0.000062378625,0.0005690265],"category_scores_gemma":[0.00010206724,0.00067947875,0.00073447323,0.0014442761,0.00019290062,0.00011269907,0.00018173766,0.0014164554,0.00025188847],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007028834,0.0050296797,0.0008411721,0.0043884316,0.00017092012,0.025662592,0.000023216597,0.000013598479,7.5203855e-7,0.00012781525,0.0027119536,0.96095955],"study_design_scores_gemma":[0.0041348976,0.0016403169,0.00005806491,0.016167244,0.0003123159,0.006003278,0.00007158394,0.000007336077,0.0000016899461,0.000024113537,0.9712403,0.00033887054],"about_ca_topic_score_codex":0.000029591458,"about_ca_topic_score_gemma":0.0014618533,"teacher_disagreement_score":0.96852833,"about_ca_system_score_codex":0.0037305444,"about_ca_system_score_gemma":0.0018375954,"threshold_uncertainty_score":0.99956566},"labels":[],"label_agreement":null},{"id":"W3140031112","doi":"10.1007/s11864-021-00836-1","title":"Models of Integration of Specialized Palliative Care with Oncology","year":2021,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Department of Medicine, University of Toronto; University of Toronto","keywords":"Medicine; Palliative care; Referral; Ambulatory care; Randomized controlled trial; Quality of life (healthcare); Intensive care medicine; Nursing; Family medicine; Health care; Internal medicine","score_opus":0.5283865048148864,"score_gpt":0.581279279842736,"score_spread":0.052892775027849614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3140031112","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034027777,0.99157906,0.0006014924,0.000028170285,0.0004364947,0.0014768253,0.00031698507,0.000011801881,0.005208886],"genre_scores_gemma":[0.0003689694,0.9885565,0.007918184,0.0000030052204,0.00012274846,0.00049787894,0.0024214287,0.000027861463,0.00008339695],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99754614,0.0004761461,0.0011526975,0.00041437315,0.00020133598,0.00020930417],"domain_scores_gemma":[0.9972708,0.0006870284,0.00096611324,0.00038792792,0.00061523804,0.00007284903],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000107824235,0.00040346986,0.004012367,0.0005450001,0.000020878313,0.000002009562,0.00011483888,0.00042360422,0.00008290144],"category_scores_gemma":[0.000097834105,0.0002743664,0.00053422904,0.0006217392,0.00029055594,0.00004331153,0.00004551909,0.00030242818,0.0000035783385],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014973423,0.002386387,0.00022291933,0.004988707,0.00073151634,0.000046650042,0.004921198,0.000054869342,0.0000024953627,0.0045104255,0.000053999604,0.9819311],"study_design_scores_gemma":[0.0033786576,0.0048685577,0.00002320497,0.048645236,0.0035226285,0.0000133953945,0.002947739,0.000027151327,0.000057701644,0.000076260505,0.9362521,0.00018737481],"about_ca_topic_score_codex":0.000089019966,"about_ca_topic_score_gemma":0.00043977413,"teacher_disagreement_score":0.98174375,"about_ca_system_score_codex":0.0026984503,"about_ca_system_score_gemma":0.0029833398,"threshold_uncertainty_score":0.99997085},"labels":[],"label_agreement":null},{"id":"W3169098949","doi":"10.1007/s11864-021-00856-x","title":"Current Management of Chronic Neutrophilic Leukemia","year":2021,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Ruxolitinib; Dasatinib; Oncology; Clinical trial; Internal medicine; Myelofibrosis; Imatinib; Immunology; Bone marrow; Myeloid leukemia","score_opus":0.1147755261590812,"score_gpt":0.4451971280526817,"score_spread":0.3304216018936005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169098949","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023644239,0.9911831,0.000019166286,0.00003770538,0.0026022983,0.0040756497,0.00016847052,0.00008175965,0.0015953779],"genre_scores_gemma":[0.000060468035,0.9918405,0.00060650846,0.000003065665,0.00047220278,0.0032676305,0.0031111143,0.00011260329,0.000525903],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99516577,0.00044350687,0.0018504778,0.0013110893,0.00040283176,0.0008263235],"domain_scores_gemma":[0.9970804,0.00026625986,0.00073432724,0.001531974,0.00011449108,0.000272537],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019281801,0.0010742765,0.0046687145,0.0009377673,0.000082147235,0.000015187203,0.00033004882,0.0005257659,0.0005109507],"category_scores_gemma":[0.00001850347,0.0008720777,0.001469396,0.0012288219,0.00023760878,0.00006216067,0.00030166897,0.0008488496,0.00030649398],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000021230724,0.005697889,0.000037614995,0.022417767,0.001591663,0.00064880215,0.00004787362,0.000025224956,2.3984978e-7,0.0017301809,0.00045133324,0.96733016],"study_design_scores_gemma":[0.0060913945,0.0015704622,0.00009717492,0.045437943,0.008049278,0.00039711973,0.0000266192,0.0000338718,0.0000012548574,0.00001980089,0.9378497,0.00042536436],"about_ca_topic_score_codex":0.000026862668,"about_ca_topic_score_gemma":0.000041498985,"teacher_disagreement_score":0.9669048,"about_ca_system_score_codex":0.064061314,"about_ca_system_score_gemma":0.008949362,"threshold_uncertainty_score":0.999373},"labels":[],"label_agreement":null},{"id":"W3172328329","doi":"10.1007/s11864-021-00854-z","title":"Radiation Necrosis from Stereotactic Radiosurgery—How Do We Mitigate?","year":2021,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Radiosurgery; Medicine; Bevacizumab; Radiation therapy; Medical physics; Radiology; Surgery; Chemotherapy","score_opus":0.14548806542247372,"score_gpt":0.43391227758448064,"score_spread":0.2884242121620069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172328329","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026401095,0.9920258,0.000025583171,0.0015234507,0.0027213483,0.002346284,0.0008635698,0.00007394774,0.00015598664],"genre_scores_gemma":[0.00009835517,0.986988,0.001385137,0.000023729366,0.0005703835,0.0023216195,0.007956327,0.00008914953,0.00056728005],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99601126,0.0010541185,0.0009804917,0.001110267,0.00027274893,0.00057111605],"domain_scores_gemma":[0.9968097,0.0012839575,0.0005520575,0.0009546317,0.00008367117,0.00031597982],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022613558,0.0008586217,0.0038325854,0.0006755728,0.00012565589,0.00009169107,0.00013481043,0.00054984103,0.00078010204],"category_scores_gemma":[0.000119522876,0.00065485993,0.0013713283,0.0007607729,0.000118176395,0.00010583557,0.00007341472,0.0005391739,0.00021929],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001950834,0.004088442,0.00032185193,0.001191243,0.001743711,0.0006859425,0.00013776802,0.0000018104093,1.8851897e-7,0.00023696916,0.0019711843,0.9896014],"study_design_scores_gemma":[0.0032858993,0.00084828015,0.00012761912,0.010418513,0.008313814,0.00031887038,0.00006858183,0.000009480342,0.0000014177928,0.00006049484,0.97615206,0.00039494113],"about_ca_topic_score_codex":0.00008195743,"about_ca_topic_score_gemma":0.0000429938,"teacher_disagreement_score":0.98920643,"about_ca_system_score_codex":0.0055503,"about_ca_system_score_gemma":0.0017667697,"threshold_uncertainty_score":0.9995903},"labels":[],"label_agreement":null},{"id":"W3188859885","doi":"10.1007/s11864-003-0006-y","title":"Insulinoma","year":2003,"lang":"en","type":"article","venue":"Current Treatment Options in Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Insulinoma; Enucleation; Palpation; Multiple endocrine neoplasia; Gold standard (test); Sunitinib; Pancreas; Radiology; Surgery; Cancer; Internal medicine","score_opus":0.09310704355213165,"score_gpt":0.44480105338771364,"score_spread":0.35169400983558197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188859885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9618357,0.005166417,0.00004024745,0.0012707232,0.00073749706,0.00093431416,0.000008745519,0.00007891958,0.029927447],"genre_scores_gemma":[0.99035585,0.0052854945,0.0025349585,0.00004767119,0.00007716853,0.0004339003,0.000028878474,0.000015952059,0.0012201295],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988927,0.00015000324,0.0002208593,0.00027564302,0.00011677591,0.00034401243],"domain_scores_gemma":[0.99938554,0.00013243708,0.000035272235,0.00025832994,0.000044214972,0.00014419632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000063662774,0.00013309346,0.00026749738,0.00026500065,0.00004893411,0.0000058581186,0.000049822273,0.000012462636,0.00031301845],"category_scores_gemma":[0.00019984508,0.00010715232,0.00007025304,0.00030625213,0.000100541,0.000055974484,0.000017456401,0.00017921365,0.00026202388],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049605477,0.022981519,0.32701954,0.000101748636,0.00013288636,0.007483712,0.00029734982,0.00015100476,0.001597591,0.058360238,0.0024379299,0.57894045],"study_design_scores_gemma":[0.0058113197,0.0032086389,0.016417958,0.00003098259,0.00003879059,0.0012663518,0.00012000873,0.000038376133,0.0011649834,0.00095018244,0.97084355,0.00010886664],"about_ca_topic_score_codex":0.0000076235215,"about_ca_topic_score_gemma":0.000049484606,"teacher_disagreement_score":0.9684056,"about_ca_system_score_codex":0.0008652927,"about_ca_system_score_gemma":0.00033919152,"threshold_uncertainty_score":0.4369545},"labels":[],"label_agreement":null},{"id":"W3191985722","doi":"10.1007/s11864-002-0031-2","title":"Carcinoid tumors","year":2002,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Lanreotide; Carcinoid syndrome; Octreotide; Carcinoid Heart Disease; Carcinoid tumors; Neuroendocrine tumors; Somatostatin; Metastasis; Endocrine system; Gastroenterology; Internal medicine; Surgery; Cancer; Pathology; Hormone; Acromegaly","score_opus":0.21478441182762414,"score_gpt":0.49814648917972876,"score_spread":0.2833620773521046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191985722","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057155798,0.99107397,0.0000014281658,0.00016227506,0.000775315,0.0029105071,0.000080677084,0.000100703735,0.004837949],"genre_scores_gemma":[0.000023920793,0.99300146,0.00034788175,0.000009749385,0.0003904435,0.002597096,0.00041550762,0.00007520117,0.003138741],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99692154,0.00041625195,0.00084536534,0.0007953432,0.00027493367,0.00074655004],"domain_scores_gemma":[0.9982828,0.00040134808,0.00023262312,0.00071800203,0.00006199025,0.00030326121],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008267857,0.000604721,0.0026730152,0.0010861664,0.00007622263,0.000015460817,0.00022338679,0.00006475637,0.000590494],"category_scores_gemma":[0.0001427199,0.00044317957,0.0006305044,0.00076193555,0.00020646211,0.000062880434,0.00011293246,0.0008469457,0.0010939451],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013611357,0.0026591595,0.00009108339,0.0036216418,0.0000893857,0.004473355,0.00001840583,0.0000013536888,8.1450096e-8,0.0002002402,0.0012013372,0.98763037],"study_design_scores_gemma":[0.0015482855,0.00187634,0.000024780604,0.004746095,0.00071502203,0.0036555338,0.000015825774,0.000007371815,5.236768e-7,0.00002411126,0.98714364,0.00024247417],"about_ca_topic_score_codex":0.000016934957,"about_ca_topic_score_gemma":0.00003859261,"teacher_disagreement_score":0.9873879,"about_ca_system_score_codex":0.0039604786,"about_ca_system_score_gemma":0.0009977431,"threshold_uncertainty_score":0.99986315},"labels":[],"label_agreement":null},{"id":"W4212810560","doi":"10.1007/s11864-021-00929-x","title":"Natural Killer Cells: the Missing Link in Effective Treatment for High-Grade Serous Ovarian Carcinoma","year":2022,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Beatrice Hunter Cancer Research Institute; Dalhousie University","funders":"Terry Fox Research Institute","keywords":"Immunoediting; Immunosurveillance; Tumor microenvironment; Immune system; Immunotherapy; Medicine; Ovarian cancer; Myeloid-derived Suppressor Cell; Natural killer cell; Cancer research; Immunology; Cancer; Biology; Cytotoxic T cell; Internal medicine; Suppressor","score_opus":0.07730971623990514,"score_gpt":0.37313948212203113,"score_spread":0.295829765882126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212810560","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021831102,0.95310646,0.00002979237,0.00044117638,0.04080196,0.00508327,0.00005584482,0.00005909996,0.00020406755],"genre_scores_gemma":[0.0011247363,0.9779684,0.000072149494,0.00003748445,0.00023253007,0.010988984,0.0039999853,0.00006300493,0.0055127447],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955182,0.0020853651,0.00092690106,0.0008065361,0.000043589855,0.00061941176],"domain_scores_gemma":[0.9966642,0.0022568249,0.00046222485,0.0005523883,0.000037216098,0.000027127127],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031324546,0.00072353776,0.0017112608,0.0006801504,0.0005217094,0.000030113204,0.00029369778,0.00057239947,0.00078105176],"category_scores_gemma":[0.00005741642,0.00047425705,0.0007220004,0.00044057204,0.00016182376,0.00008145571,0.0000979101,0.001012345,0.00021438887],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019170692,0.0022491333,0.0000127408175,0.00028536958,0.000510469,0.00001691443,0.0005714405,0.000024134995,0.000031562096,0.00044160816,0.0014479163,0.994217],"study_design_scores_gemma":[0.004679994,0.0025139283,0.000092833754,0.0005098164,0.0009770764,0.00016088365,0.00019635663,0.000017380105,0.00003975367,0.00004328239,0.9903985,0.00037017502],"about_ca_topic_score_codex":0.00045780474,"about_ca_topic_score_gemma":0.00029124302,"teacher_disagreement_score":0.99384683,"about_ca_system_score_codex":0.008510848,"about_ca_system_score_gemma":0.00057479076,"threshold_uncertainty_score":0.99977094},"labels":[],"label_agreement":null},{"id":"W4229037395","doi":"10.1007/s11864-022-00988-8","title":"Immune Checkpoint Inhibitors for the Treatment of Gestational Trophoblastic Neoplasia: Rationale, Effectiveness, and Future Fertility","year":2022,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Sinai Health System; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Gestational trophoblastic neoplasia; Gestational trophoblastic disease; Oncology; Chemotherapy; Disease; Adverse effect; Internal medicine; Clinical trial; Pregnancy; Intensive care medicine; Gynecology; Gestation","score_opus":0.07089288282692768,"score_gpt":0.39336930976956347,"score_spread":0.3224764269426358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229037395","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018477485,0.9887753,0.00007543742,0.00030723933,0.0014323934,0.0064762817,0.0010181618,0.000021956406,0.000045439287],"genre_scores_gemma":[0.00040641724,0.9805713,0.0005675429,0.0000024869976,0.0003576408,0.016201442,0.0017916854,0.000038105514,0.00006332068],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975304,0.00039673658,0.0009674091,0.0005713754,0.0002637233,0.00027033605],"domain_scores_gemma":[0.99381626,0.005211069,0.000429841,0.0003136589,0.0001393866,0.000089811976],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020818227,0.0005232573,0.0017997272,0.00032429965,0.00028140075,0.00001049579,0.00008256211,0.00014659748,0.00016196491],"category_scores_gemma":[0.00018217035,0.00032547963,0.00071358035,0.00037263625,0.00032091452,0.000036368245,0.00004461039,0.00018709368,0.000006001956],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006863892,0.0065416144,0.00016149865,0.005027393,0.001278454,0.000018494691,0.00032156115,0.00008172904,0.0000012061466,0.0013709947,0.000037017468,0.98447365],"study_design_scores_gemma":[0.0047836765,0.0043552285,0.022371095,0.0009133675,0.0044681565,0.000056839053,0.00027836292,0.00006921209,0.0000012434151,0.00016433632,0.96234864,0.0001898144],"about_ca_topic_score_codex":0.000015601538,"about_ca_topic_score_gemma":0.00003089759,"teacher_disagreement_score":0.9842838,"about_ca_system_score_codex":0.0033230523,"about_ca_system_score_gemma":0.0017169164,"threshold_uncertainty_score":0.9999197},"labels":[],"label_agreement":null},{"id":"W4283827551","doi":"10.1007/s11864-022-00993-x","title":"Incorporating Molecular Diagnostics into Treatment Paradigms for Endometrial Cancer","year":2022,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Pembrolizumab; Medicine; Endometrial cancer; Oncology; Lenvatinib; Internal medicine; DNA mismatch repair; Trastuzumab; Population; Adjuvant; Cancer; Cancer research; Immunotherapy; Thyroid cancer; Breast cancer","score_opus":0.22744445458158166,"score_gpt":0.4979339040913149,"score_spread":0.2704894495097332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283827551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009415091,0.9854966,0.000117424934,0.00016767989,0.0038623407,0.008474936,0.0012021142,0.00008364268,0.00050114444],"genre_scores_gemma":[0.00005635066,0.9430374,0.0017958997,0.000030347128,0.001007284,0.048137773,0.005626531,0.00011773809,0.0001906621],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959506,0.0004803376,0.0014156149,0.0011249178,0.00034631355,0.0006822347],"domain_scores_gemma":[0.9948136,0.0034498356,0.00069326966,0.00063220575,0.00007154123,0.0003395387],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024119741,0.0009842913,0.003980512,0.0014100794,0.00026798501,0.000032031297,0.00023193867,0.000431,0.00076285395],"category_scores_gemma":[0.00051712594,0.00072027906,0.0015522717,0.0018313914,0.00013492136,0.000055527114,0.0001202667,0.00042300194,0.000040020102],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033918166,0.006839773,0.00017147994,0.0020516943,0.0014843977,0.00025291002,0.00009886405,0.00003038528,4.6101272e-7,0.00136061,0.00011224274,0.987258],"study_design_scores_gemma":[0.01566112,0.01090501,0.0000068816425,0.0016697388,0.0081171775,0.00005963358,0.000030867403,0.000015291715,0.000004417218,0.00041738007,0.9626517,0.00046075985],"about_ca_topic_score_codex":0.00047404144,"about_ca_topic_score_gemma":0.0002848649,"teacher_disagreement_score":0.9867972,"about_ca_system_score_codex":0.021186987,"about_ca_system_score_gemma":0.003174406,"threshold_uncertainty_score":0.99952483},"labels":[],"label_agreement":null},{"id":"W4291202004","doi":"10.1007/s11864-022-01009-4","title":"Targeting the FGFR Pathway in Urothelial Carcinoma: the Future Is Now","year":2022,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; Canada Research Chairs; University Health Network","funders":"","keywords":"Medicine; Urothelial carcinoma; Metastatic Urothelial Carcinoma; Urothelial cancer; Targeted therapy; Precision medicine; Fibroblast growth factor receptor; Oncology; Dosing; Immunotherapy; Cancer research; Internal medicine; Cancer; Chemotherapy; Bladder cancer; Fibroblast growth factor; Pathology","score_opus":0.09544036010765244,"score_gpt":0.401192488017979,"score_spread":0.3057521279103266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291202004","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001776761,0.9879074,0.0000024515834,0.0019190288,0.0034880242,0.0043389522,0.00043777266,0.000039620845,0.0016890791],"genre_scores_gemma":[0.00022414507,0.98898095,0.00004333459,0.0001775068,0.0015681188,0.007399412,0.0006719737,0.00007698753,0.00085756613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99652946,0.0009281895,0.00088843337,0.0007444311,0.00031347905,0.0005960081],"domain_scores_gemma":[0.9981973,0.0005484368,0.00031359072,0.00081002456,0.000032376964,0.000098281096],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003877924,0.0006780272,0.0017568374,0.000349755,0.00036638742,0.000027126649,0.00041580488,0.00031936684,0.0014576374],"category_scores_gemma":[0.000030637824,0.0003393879,0.00069924287,0.000847511,0.00017485971,0.000043285894,0.00017354802,0.0012703111,0.00015414547],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000580638,0.0020291803,0.0007630961,0.0006189827,0.00023297989,0.00017418808,0.0010305038,0.0000053576828,1.3077812e-7,0.0002232379,0.0024149197,0.99244934],"study_design_scores_gemma":[0.0027779373,0.0010536959,0.00021588057,0.0006396774,0.0010995596,0.0001886701,0.0004255996,0.000011063749,4.696248e-7,0.000045057044,0.9932951,0.00024733687],"about_ca_topic_score_codex":0.0001336554,"about_ca_topic_score_gemma":0.00033634307,"teacher_disagreement_score":0.99220204,"about_ca_system_score_codex":0.004718902,"about_ca_system_score_gemma":0.0025948796,"threshold_uncertainty_score":0.9999058},"labels":[],"label_agreement":null},{"id":"W4291891254","doi":"10.1007/s11864-022-01002-x","title":"Role of Stereotactic Radiation Therapy in Operable and Inoperable Early-Stage Non-small Cell Lung Cancer","year":2022,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Lung cancer; Radiation therapy; Stage (stratigraphy); Oncology; Cancer; Internal medicine; Radiology","score_opus":0.06807786759511557,"score_gpt":0.40799979988079693,"score_spread":0.33992193228568135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291891254","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06663355,0.92843264,4.7265806e-7,0.000039250408,0.00043554485,0.003566219,0.00014105633,0.000013223986,0.0007380353],"genre_scores_gemma":[0.003151057,0.9871751,0.00008507311,0.000012490393,0.00008536166,0.008632953,0.00034102812,0.000046868783,0.0004700671],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979482,0.00028525208,0.0007048099,0.00058419624,0.00013587225,0.00034161872],"domain_scores_gemma":[0.99889314,0.00028410036,0.00031374613,0.00037999943,0.000029698254,0.0000993041],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016939742,0.00042633992,0.0017607044,0.0005758536,0.00007389567,0.00001652758,0.00010324504,0.0002031757,0.00062794646],"category_scores_gemma":[0.000007720075,0.00032876324,0.00022721225,0.00046813925,0.000046155146,0.00007288169,0.00006257425,0.0003825898,0.0000057339066],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053611482,0.0045408704,0.04873493,0.0028093574,0.00032212996,0.000034862034,0.00088733784,0.00005929983,0.000001136088,0.000029840494,0.00004324528,0.94248337],"study_design_scores_gemma":[0.00623994,0.0023665288,0.005578339,0.0028874096,0.0011673574,0.0000119077,0.00010239728,0.00012695967,0.000009515409,0.0000029533244,0.9812626,0.00024405583],"about_ca_topic_score_codex":0.0021874104,"about_ca_topic_score_gemma":0.0006888491,"teacher_disagreement_score":0.9812194,"about_ca_system_score_codex":0.0068874313,"about_ca_system_score_gemma":0.001452715,"threshold_uncertainty_score":0.99991643},"labels":[],"label_agreement":null},{"id":"W4323294209","doi":"10.1007/s11864-023-01059-2","title":"Trimodality Treatment of Extremity Soft Tissue Sarcoma: Where Do We Go Now?","year":2023,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Soft tissue sarcoma; Chemoradiotherapy; Clinical trial; Chemotherapy; Sarcoma; Radiation therapy; Oncology; Internal medicine; Surgery; Soft tissue; Pathology","score_opus":0.20565851597800436,"score_gpt":0.4755904172331465,"score_spread":0.2699319012551421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323294209","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046031582,0.990147,0.000012052166,0.00060413784,0.0014284448,0.0056673256,0.00088719034,0.00018622456,0.0006073186],"genre_scores_gemma":[0.00017652808,0.9898311,0.0004604746,0.000003012187,0.00041204697,0.006397453,0.0011446885,0.00014002026,0.0014346945],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946642,0.0007075257,0.00202447,0.0013843129,0.00039242234,0.00082704984],"domain_scores_gemma":[0.995637,0.001551342,0.0008329473,0.0014732995,0.00013587475,0.0003695312],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00025257468,0.001293945,0.006033138,0.001000356,0.0001353826,0.000026386342,0.00025932348,0.00083661184,0.00041142476],"category_scores_gemma":[0.00006146297,0.0009046345,0.0016543936,0.0011427613,0.00028604708,0.00006728906,0.0001186313,0.00036571547,0.001022811],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080104925,0.031040668,0.0037582756,0.004334589,0.0015126126,0.00065701565,0.00021174093,0.0000029106654,3.4906756e-7,0.0005070034,0.0011267586,0.956768],"study_design_scores_gemma":[0.006716618,0.0043035788,0.0008444167,0.00997999,0.008135395,0.00024813873,0.000056215995,0.0000074405057,0.000004389596,0.00016300367,0.9690535,0.00048733025],"about_ca_topic_score_codex":0.00020142844,"about_ca_topic_score_gemma":0.000714085,"teacher_disagreement_score":0.96792674,"about_ca_system_score_codex":0.009753866,"about_ca_system_score_gemma":0.002060361,"threshold_uncertainty_score":0.9999812},"labels":[],"label_agreement":null},{"id":"W4324017998","doi":"10.1007/s11864-023-01060-9","title":"Integrating Palliative Care into Oncology Care Worldwide: The Right Care in the Right Place at the Right Time","year":2023,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; University Health Network","funders":"","keywords":"Palliative care; Medicine; Context (archaeology); Nursing; Ambulatory care; End-of-life care; Point of care; Mentorship; Family medicine; Health care; Medical education; Economic growth","score_opus":0.19634782246600438,"score_gpt":0.5202719550405129,"score_spread":0.3239241325745086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324017998","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006452817,0.97797096,0.0000050284884,0.0015769312,0.0014933144,0.005111903,0.0005564226,0.00007783907,0.012562323],"genre_scores_gemma":[0.0004321574,0.98780084,0.0003261602,0.00009835527,0.00062386313,0.004833366,0.004454431,0.00008918238,0.001341642],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932012,0.002967171,0.0015719197,0.0010086941,0.00048774132,0.0007632829],"domain_scores_gemma":[0.98981285,0.0074879634,0.0008870379,0.001245576,0.00044242796,0.00012415217],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055904844,0.0010371191,0.0031537141,0.0006238073,0.0006023642,0.000035778063,0.0009489832,0.00074475165,0.00039393717],"category_scores_gemma":[0.00047226172,0.0004485653,0.0009966451,0.0016671582,0.000798432,0.00006471346,0.0003563709,0.0017159142,0.0005100805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011946938,0.000703281,0.00081909733,0.004703071,0.0007854351,0.000532379,0.1295636,0.000042763433,4.535348e-7,0.001434299,0.0050214366,0.8562747],"study_design_scores_gemma":[0.0018187339,0.0014736288,0.00009576147,0.015270461,0.002516331,0.000037487735,0.031980902,0.0000142467425,0.00000658328,0.00007124802,0.94634384,0.0003707483],"about_ca_topic_score_codex":0.0003591688,"about_ca_topic_score_gemma":0.030930236,"teacher_disagreement_score":0.94132245,"about_ca_system_score_codex":0.014937178,"about_ca_system_score_gemma":0.0024114137,"threshold_uncertainty_score":0.9997966},"labels":[],"label_agreement":null},{"id":"W4377221133","doi":"10.1007/s11864-023-01097-w","title":"Critical Appraisal of Proton Therapy for Patients with Central Nervous System (CNS) Malignancies","year":2023,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Proton therapy; Central nervous system; Radiation therapy; Disease; Surgery; Pathology; Internal medicine","score_opus":0.11612876719487061,"score_gpt":0.4503622528551682,"score_spread":0.33423348566029754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377221133","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0057915715,0.9775237,0.000023695813,0.00006639622,0.0015543384,0.013953811,0.00090954255,0.00011132201,0.00006566046],"genre_scores_gemma":[0.0016397459,0.9682154,0.0005800618,0.0000020066996,0.00018357336,0.02740423,0.0018707905,0.00008993319,0.0000142248955],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974358,0.00019676825,0.00092248106,0.0006216202,0.00024216442,0.00058116345],"domain_scores_gemma":[0.9973907,0.0014369811,0.00033265792,0.00044084154,0.0002305842,0.00016825041],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010834588,0.0005772887,0.0025483158,0.0004896471,0.0000808578,0.000015757927,0.00011915091,0.00032068108,0.000014815527],"category_scores_gemma":[0.00013407934,0.0003495532,0.00060217606,0.0004411702,0.00017706824,0.000044252105,0.000033767297,0.00016417493,0.000023150038],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026605686,0.01690487,0.006070894,0.021735035,0.0009466571,0.00007587244,0.00012681655,0.000004536451,1.3322946e-7,0.0028858746,0.00016289264,0.9508204],"study_design_scores_gemma":[0.01051981,0.013221274,0.0035803623,0.024198342,0.0034950627,0.00004595768,0.00009629885,0.000018253055,0.000004678895,0.000009619337,0.9444529,0.00035745476],"about_ca_topic_score_codex":0.000018932978,"about_ca_topic_score_gemma":0.000017572063,"teacher_disagreement_score":0.9504629,"about_ca_system_score_codex":0.0019699677,"about_ca_system_score_gemma":0.00086022203,"threshold_uncertainty_score":0.99989563},"labels":[],"label_agreement":null},{"id":"W4386695406","doi":"10.1007/s11864-023-01125-9","title":"The Crying Need for a Better Response Assessment in Rectal Cancer","year":2023,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Crying; Colorectal cancer; Oncology; Internal medicine; Cancer; Psychiatry","score_opus":0.30426993775718675,"score_gpt":0.5704413850166792,"score_spread":0.26617144725949243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386695406","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028510017,0.98495895,0.000008606201,0.0016536894,0.0025126417,0.007390757,0.00025590972,0.00009341435,0.00027503454],"genre_scores_gemma":[0.00008984736,0.9549874,0.0003797047,0.000022571814,0.00030106338,0.042785805,0.0003155189,0.00009144915,0.0010266453],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99619204,0.00094414136,0.0011103378,0.0007887485,0.00023497702,0.00072978187],"domain_scores_gemma":[0.99393845,0.0049981,0.0003274669,0.00051719917,0.00007344413,0.00014532982],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087854086,0.00060168625,0.0022196828,0.00071025296,0.00019309093,0.000036045523,0.00020032898,0.00040222783,0.000058340025],"category_scores_gemma":[0.00024805343,0.00037378655,0.0007643147,0.0011037813,0.00014690855,0.00004431329,0.00011578248,0.0006623815,0.000059255857],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010387829,0.0013881689,0.0006529132,0.0012028804,0.00049894373,0.00022444966,0.00010978412,0.000007326424,3.3154546e-7,0.00009957081,0.0003319577,0.9944449],"study_design_scores_gemma":[0.0046946467,0.002053813,0.0020981363,0.0072854212,0.0013000631,0.00005920184,0.00006074647,0.00007767427,1.8516663e-7,0.000086492495,0.9820154,0.00026827725],"about_ca_topic_score_codex":0.00011273334,"about_ca_topic_score_gemma":0.0013653106,"teacher_disagreement_score":0.9941766,"about_ca_system_score_codex":0.017239533,"about_ca_system_score_gemma":0.0033156318,"threshold_uncertainty_score":0.99987143},"labels":[],"label_agreement":null},{"id":"W4387393214","doi":"10.1007/s11864-023-01132-w","title":"Optimal Therapeutic Strategy for PD-L1 Negative Metastatic Non-Small Cell Lung Cancer: A Decision-Making Guide Based on Clinicopathological and Molecular Features","year":2023,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Durvalumab; Medicine; Atezolizumab; Pembrolizumab; Tremelimumab; Nivolumab; Ipilimumab; Oncology; Lung cancer; PD-L1; Internal medicine; Immunotherapy; Avelumab; Immune checkpoint; Blockade; Cancer; Chemotherapy; Receptor","score_opus":0.14797085779575342,"score_gpt":0.5008112849415937,"score_spread":0.35284042714584024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387393214","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010096774,0.99037224,0.0015927241,0.00012105757,0.0005953896,0.0057613547,0.0002841495,0.00005974117,0.0002036941],"genre_scores_gemma":[0.00046253434,0.9856017,0.006949009,0.00016020604,0.00011899926,0.0061777825,0.00030894327,0.00008206913,0.00013870462],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99696463,0.00040776908,0.001041068,0.0009086162,0.00018031782,0.00049758225],"domain_scores_gemma":[0.99548,0.0034253488,0.00046929336,0.00042584623,0.000087225795,0.00011230185],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049132283,0.00067547814,0.0021940893,0.00060090714,0.00013712162,0.000040673858,0.00017695571,0.00039986565,0.00005670927],"category_scores_gemma":[0.000107466054,0.00045973266,0.00081895746,0.00051748584,0.00018538929,0.000026590393,0.00004639796,0.0004845673,0.0000074437444],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013426968,0.0015800673,0.000034134064,0.0031281898,0.00048490972,0.00023237441,0.00009330335,0.0007779477,0.0000019251313,0.00003676402,0.0005267342,0.99176097],"study_design_scores_gemma":[0.01739315,0.015316755,0.00063162635,0.03784275,0.011767788,0.00016284427,0.00027114872,0.0062904404,0.000008049599,0.00019703337,0.9090858,0.0010326102],"about_ca_topic_score_codex":0.00002921702,"about_ca_topic_score_gemma":0.00008401492,"teacher_disagreement_score":0.9907283,"about_ca_system_score_codex":0.0020632795,"about_ca_system_score_gemma":0.0017891832,"threshold_uncertainty_score":0.9997854},"labels":[],"label_agreement":null},{"id":"W4388797269","doi":"10.1007/s11864-023-01145-5","title":"The Evolving Treatment Landscape of Medullary Thyroid Cancer","year":2023,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Università degli Studi di Brescia","keywords":"Medicine; Medullary cavity; Thyroid cancer; Medullary thyroid cancer; Oncology; Cancer; Thyroid; Internal medicine","score_opus":0.16793920905984108,"score_gpt":0.4785485377376829,"score_spread":0.31060932867784186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388797269","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019150242,0.9928671,9.930519e-7,0.00047159064,0.0019174587,0.0032688372,0.00042142413,0.00009065517,0.0007704145],"genre_scores_gemma":[0.000086004926,0.9857206,0.000072774616,0.0000054367397,0.00046365566,0.011891306,0.00053803343,0.000097734046,0.0011244639],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968299,0.0003233557,0.0012229739,0.0007306927,0.00027273924,0.0006203306],"domain_scores_gemma":[0.99681956,0.001419372,0.0005919164,0.00087603426,0.00010764018,0.00018546796],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020937146,0.0007535078,0.0028856057,0.0005235208,0.00020944377,0.000025571837,0.00022077658,0.00035930125,0.00013965316],"category_scores_gemma":[0.00005579753,0.00040697688,0.0010750261,0.000827628,0.00019264521,0.000041461615,0.00009044162,0.00029887242,0.00015075688],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047244444,0.0032700587,0.0008453847,0.0020412847,0.0018476025,0.00010677879,0.0001756966,0.000014243292,2.0493515e-7,0.0003464905,0.002176174,0.9891288],"study_design_scores_gemma":[0.0031710172,0.0031434083,0.00043666642,0.009775798,0.0054417495,0.000060001752,0.00010736754,0.000021338157,0.0000021179903,0.000031638057,0.9775501,0.00025880628],"about_ca_topic_score_codex":0.00024649134,"about_ca_topic_score_gemma":0.0015472402,"teacher_disagreement_score":0.98887,"about_ca_system_score_codex":0.0070994264,"about_ca_system_score_gemma":0.002779386,"threshold_uncertainty_score":0.99983823},"labels":[],"label_agreement":null}]}